<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by the Simple XML sitemap Drupal module: https://drupal.org/project/simple_sitemap.-->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.hepactive.org/</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/"/>
  <xhtml:link rel="alternate" hreflang="en" href="https://www.hepactive.org/"/>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/"/>
  <xhtml:link rel="alternate" hreflang="en" href="https://www.hepactive.org/"/>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/konsensus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/konsensus"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/obsa-diagnostika-na-virusnite-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/obsa-diagnostika-na-virusnite-hepatiti"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hranene-pri-hora-s-cernodrobni-zabolavania</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hranene-pri-hora-s-cernodrobni-zabolavania"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2008"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-3</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-3"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-4</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-4"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-1"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-2</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-cast-2"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-3</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-3"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/lecenie"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nay-vazhnoto-za-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nay-vazhnoto-za-khepatit"/>
  <lastmod>2019-12-29T08:18:02+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-v"/>
  <lastmod>2018-06-19T22:23:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-khepatit-s"/>
  <lastmod>2020-01-07T13:08:38+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nay-vazhnoto-za-khepatit-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nay-vazhnoto-za-khepatit-e"/>
  <lastmod>2019-12-29T08:18:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-d"/>
  <lastmod>2018-06-21T09:55:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diagnostika-na-khepatit-i-khepatit-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diagnostika-na-khepatit-i-khepatit-e"/>
  <lastmod>2020-11-18T19:50:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diagnostika-na-hepatit-s-i-hepatit-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diagnostika-na-hepatit-s-i-hepatit-d"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/alkokholen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/alkokholen-khepatit"/>
  <lastmod>2020-09-12T10:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/medikamentozen-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/medikamentozen-hepatit"/>
  <lastmod>2018-06-25T07:20:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diagnostika-na-ostrite-virusni-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diagnostika-na-ostrite-virusni-hepatiti"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diagnostika-na-hronicnite-virusni-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diagnostika-na-hronicnite-virusni-hepatiti"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/markeri-za-hepatit-v-infekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/markeri-za-hepatit-v-infekcia"/>
  <lastmod>2018-06-19T14:15:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/cernodrobna-biopsia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/cernodrobna-biopsia"/>
  <lastmod>2018-06-20T21:16:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sistemi-za-ocenka-na-histologicnata-aktivnost-pri-hronicni-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sistemi-za-ocenka-na-histologicnata-aktivnost-pri-hronicni-hepatiti"/>
  <lastmod>2018-06-21T08:36:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2009"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-doc-d-r-kr-antonov-za-hronicnite-hepatiti-profilaktika-nacini-za-zarazavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-doc-d-r-kr-antonov-za-hronicnite-hepatiti-profilaktika-nacini-za-zarazavane"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/svremenno-lecenie-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/svremenno-lecenie-na-hepatit-v"/>
  <lastmod>2018-04-27T16:57:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/ustroistvo-i-funkcii-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/ustroistvo-i-funkcii-na-cernia-drob"/>
  <lastmod>2018-06-20T21:16:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hraneneto-i-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hraneneto-i-cernia-drob"/>
  <lastmod>2018-06-21T08:32:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/avtoimunen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/avtoimunen-khepatit"/>
  <lastmod>2019-12-29T08:34:29+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hranitelni-nuzdi-pri-nalicie-na-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hranitelni-nuzdi-pri-nalicie-na-ciroza"/>
  <lastmod>2018-06-24T17:31:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uni-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uni-2008"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-s-i-bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-s-i-bremennost"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2009"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kak-da-se-lekuvam-sistemata-za-lecenie-na-hronicni-virusni-hepatiti-v-blgaria</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kak-da-se-lekuvam-sistemata-za-lecenie-na-hronicni-virusni-hepatiti-v-blgaria"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/treatment</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/treatment"/>
  <lastmod>2026-02-19T13:50:44+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-septemvri-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-septemvri-2008"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/naucni-publikacii-za-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/naucni-publikacii-za-hepatit-v"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-oktomvri-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-oktomvri-2008"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uli-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uli-2008"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2008"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/patomorfologicni-promeni-v-cernia-drob-pri-cernodrobni-zabolavania</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/patomorfologicni-promeni-v-cernia-drob-pri-cernodrobni-zabolavania"/>
  <lastmod>2018-06-19T14:53:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-d-r-r-balabanska-praktiki-pri-lecenieto-na-hronicnite-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-d-r-r-balabanska-praktiki-pri-lecenieto-na-hronicnite-hepatiti"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/medicinski-recnik</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/medicinski-recnik"/>
  <lastmod>2018-06-19T19:53:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2009"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/naucni-publikacii-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/naucni-publikacii-za-hepatit-s"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervuta-ss-specialisti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervuta-ss-specialisti"/>
  <lastmod>2018-04-27T16:57:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-avgust-2008</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-avgust-2008"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/obzor-na-naucnite-publikacii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/obzor-na-naucnite-publikacii"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/prevencia-i-zarazavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/prevencia-i-zarazavane"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zivot-s-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zivot-s-hepatita"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/okultnia-hepatit-s-skritata-infekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/okultnia-hepatit-s-skritata-infekcia"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zaguba-na-sluha-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zaguba-na-sluha-i-hepatit-s"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/alkoholt-i-kak-toi-vliae-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/alkoholt-i-kak-toi-vliae-na-cernia-drob"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/izvncernodrobni-proavi-pri-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/izvncernodrobni-proavi-pri-hepatit-c"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hranene-vvedenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hranene-vvedenie"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/testove-za-virusen-tovar-virusno-natovarvane-pri-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/testove-za-virusen-tovar-virusno-natovarvane-pri-hepatit-c"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/virusite-i-imunnata-sistema</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/virusite-i-imunnata-sistema"/>
  <lastmod>2020-11-18T19:48:59+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/predpazvane-ot-zarazavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/predpazvane-ot-zarazavane"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-1"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hranitelni-nuzdi-na-hora-s-ostr-i-hronicen-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hranitelni-nuzdi-na-hora-s-ostr-i-hronicen-hepatit"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-referencii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-upravlenie-na-hronicnia-hepatit-v-referencii"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2009"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vaksina-sresu-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vaksina-sresu-hepatit"/>
  <lastmod>2018-06-19T22:54:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vaksina-sresu-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vaksina-sresu-hepatit-v"/>
  <lastmod>2018-06-19T13:27:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kombinirana-vaksina-sresu-hepatit-i-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kombinirana-vaksina-sresu-hepatit-i-hepatit-v"/>
  <lastmod>2018-06-19T13:27:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vaksini</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vaksini"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/narcnik-za-traen-otgovor-pri-lecenie-s-peginterferon-alfa-2a-pri-hbeag-otricatelen-hronicen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/narcnik-za-traen-otgovor-pri-lecenie-s-peginterferon-alfa-2a-pri-hbeag-otricatelen-hronicen"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/list-fakti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/list-fakti"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-v-list-fakti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-v-list-fakti"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-s-list-fakti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-s-list-fakti"/>
  <lastmod>2018-05-12T15:04:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mai-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mai-2009"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-2</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-2"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-4</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-4"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-5</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-5"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-kontrolovladavane-na-stranicnite-efekti-ot-terapiata-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-kontrolovladavane-na-stranicnite-efekti-ot-terapiata-na-hepatit-s"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/uvod</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/uvod"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/1-zapazete-pozitivnia-nacin-na-mislenenaglasa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/1-zapazete-pozitivnia-nacin-na-mislenenaglasa"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/2-stranicni-efekti-koito-iziskvat-spesno-vnimanie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/2-stranicni-efekti-koito-iziskvat-spesno-vnimanie"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/3-bolki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/3-bolki"/>
  <lastmod>2018-06-19T14:13:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/4-umora-i-sn</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/4-umora-i-sn"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/5-umstveni-i-psihiatricni-simptomi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/5-umstveni-i-psihiatricni-simptomi"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/6-simptomi-svrzani-s-adeneto-i-hranata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/6-simptomi-svrzani-s-adeneto-i-hranata"/>
  <lastmod>2018-05-12T15:04:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/7-koza-kosa-nokti-oci</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/7-koza-kosa-nokti-oci"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/8-krvni-deficiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/8-krvni-deficiti"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/9-razni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/9-razni"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/10-nakolko-dumi-otpraveni-km-semeistvoto-i-priatelite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/10-nakolko-dumi-otpraveni-km-semeistvoto-i-priatelite"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uni-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uni-2009"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uli-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uli-2009"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-doc-d-r-kr-antonov-otzivi-ot-konferenciata-na-easl-2009-god</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-doc-d-r-kr-antonov-otzivi-ot-konferenciata-na-easl-2009-god"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-6</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-6"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-7</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-7"/>
  <lastmod>2018-05-12T15:05:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-avgust-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-avgust-2009"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2008-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2008-godina"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2009-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2009-godina"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-f-virus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-f-virus"/>
  <lastmod>2018-06-25T07:19:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-g-virus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-g-virus"/>
  <lastmod>2018-06-25T07:19:31+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/tt-virus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/tt-virus"/>
  <lastmod>2018-06-25T07:19:11+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/ne-hepatitni-virusi-pricinavasi-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/ne-hepatitni-virusi-pricinavasi-hepatit"/>
  <lastmod>2018-06-25T07:18:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/ekzoticni-virusni-infekcii-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/ekzoticni-virusni-infekcii-na-cernia-drob"/>
  <lastmod>2018-06-25T07:15:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-8</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-8"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sen-virus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sen-virus"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/levkopenia-i-trombocitopenia-pri-lecenie-s-interferon</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/levkopenia-i-trombocitopenia-pri-lecenie-s-interferon"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-9</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-9"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-septemvri-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-septemvri-2009"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-oktomvri-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-oktomvri-2009"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-10</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-10"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2009"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstva"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bala-kniga-za-tezestta-na-virusa-na-hepatit-s-v-blgaria</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bala-kniga-za-tezestta-na-virusa-na-hepatit-s-v-blgaria"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rkovodstvo-za-sledvasi-stpki-kogato-lecenieto-ne-raboti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rkovodstvo-za-sledvasi-stpki-kogato-lecenieto-ne-raboti"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-11</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-11"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2009</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2009"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/naucni-konferencii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/naucni-konferencii"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/60-ta-godisna-sresa-na-amerikanskata-asociacia-za-izucavane-bolestite-na-cernia-drob-aasld</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/60-ta-godisna-sresa-na-amerikanskata-asociacia-za-izucavane-bolestite-na-cernia-drob-aasld"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/otzivi-ot-godisnata-konferencia-na-evropeiskata-asociacia-za-izucavane-na-cernia-drob-easl</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/otzivi-ot-godisnata-konferencia-na-evropeiskata-asociacia-za-izucavane-na-cernia-drob-easl"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2009-cast-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2009-cast-1"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2010-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2010-godina"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2010"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-s-pri-hora-ziveesi-s-hiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-s-pri-hora-ziveesi-s-hiv"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-b-pri-hora-ziveesi-s-hiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-b-pri-hora-ziveesi-s-hiv"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/cudotvorniat-phyllanthus-nai-cennata-bilka-v-sveta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/cudotvorniat-phyllanthus-nai-cennata-bilka-v-sveta"/>
  <lastmod>2018-06-24T17:25:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2009-cast-2</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2009-cast-2"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-broi-12</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-broi-12"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2009-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2009-godina"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2010"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vazni-predizvikatelstva-pred-upravlenieto-kontroliraneto-na-nvv-pri-bremenni-zeni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vazni-predizvikatelstva-pred-upravlenieto-kontroliraneto-na-nvv-pri-bremenni-zeni"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-1"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-godina"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2010"/>
  <lastmod>2018-05-12T15:05:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-2</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-2"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bal-trn-za-cernia-drob-nakakvi-dokazatelstva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bal-trn-za-cernia-drob-nakakvi-dokazatelstva"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-doc-d-r-zulieta-gerenova-endokrinni-problemi-pri-pacenti-s-hronicen-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-doc-d-r-zulieta-gerenova-endokrinni-problemi-pri-pacenti-s-hronicen-hepatit"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/prediktori-na-progresiata-na-bolestta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/prediktori-na-progresiata-na-bolestta"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-3</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-3"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2010"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/neaktivnite-nositeli-na-virusa-na-hepatit-b-sa-s-risk-da-razviat-hepatocelularen-karcinom-i</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/neaktivnite-nositeli-na-virusa-na-hepatit-b-sa-s-risk-da-razviat-hepatocelularen-karcinom-i"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hraneneto-i-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hraneneto-i-hepatit-c"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kak-vliae-puseneto-vrhu-progresiraneto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kak-vliae-puseneto-vrhu-progresiraneto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rezumeta-i-statii-ot-provedeni-naucni-konferencii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rezumeta-i-statii-ot-provedeni-naucni-konferencii"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/dobavaneto-na-vitamin-d-km-konvencionalnata-terapia-s-pegiliran-interferon-plus-ribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/dobavaneto-na-vitamin-d-km-konvencionalnata-terapia-s-pegiliran-interferon-plus-ribavirin"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcvzapoznavane-s-hranitelnite-dobavki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcvzapoznavane-s-hranitelnite-dobavki"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mai-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mai-2010"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/laboratoria-po-porfirii-i-molekularna-diagnostika-na-cernodrobni-zabolavania-v-umbal-sveti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/laboratoria-po-porfirii-i-molekularna-diagnostika-na-cernodrobni-zabolavania-v-umbal-sveti"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-4</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-4"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-prof-d-r-konstantin-cernev-specificni-problemi-pri-prosledavaneto-i-lecenieto-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-prof-d-r-konstantin-cernev-specificni-problemi-pri-prosledavaneto-i-lecenieto-na"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-5</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-5"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uni-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uni-2010"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/silibinint-kato-spasitelno-lecenie-na-zarazeni-s-nsv-pacienti-koito-ne-davat-optimalen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/silibinint-kato-spasitelno-lecenie-na-zarazeni-s-nsv-pacienti-koito-ne-davat-optimalen"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/prezentacia-hranene-pri-hronicni-cernodrobni-zabolavania</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/prezentacia-hranene-pri-hronicni-cernodrobni-zabolavania"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-i-hcv-koinfekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-i-hcv-koinfekcia"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vvedenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vvedenie"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bremennost"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/razdane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/razdane"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/period-sled-razdaneto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/period-sled-razdaneto"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diagnostika-na-hronicni-virusni-hepatiti-v-umbal-sv-ivan-rilski</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diagnostika-na-hronicni-virusni-hepatiti-v-umbal-sv-ivan-rilski"/>
  <lastmod>2018-06-20T21:23:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2010-broi-6</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2010-broi-6"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/intervu-s-doc-dean-zelev-ostr-hepatit-b-i-specificni-grupi-pacienti-s-hronicen-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/intervu-s-doc-dean-zelev-ostr-hepatit-b-i-specificni-grupi-pacienti-s-hronicen-hepatit-b"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uli-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uli-2010"/>
  <lastmod>2018-05-31T16:13:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bezopasno-li-e-da-se-caka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bezopasno-li-e-da-se-caka"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-avgust-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-avgust-2010"/>
  <lastmod>2018-05-12T15:08:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-septemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-septemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/gent-koito-prognozira</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/gent-koito-prognozira"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nsv-obzor-septemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nsv-obzor-septemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-oktomvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-oktomvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-oktomvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-oktomvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/doklad-na-tag-za-lekarstvata-v-etap-na-razrabotka-za-2010-godina-lekarstva-za-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/doklad-na-tag-za-lekarstvata-v-etap-na-razrabotka-za-2010-godina-lekarstva-za-hepatit-b"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/doklad-na-tag-za-lekarstvata-v-etap-na-razrabotka-za-2010-godina-lekarstva-za-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/doklad-na-tag-za-lekarstvata-v-etap-na-razrabotka-za-2010-godina-lekarstva-za-hepatit-c"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-noemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-noemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/imunna-sistema-i-imunni-reakcii-pri-virusni-infekcii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/imunna-sistema-i-imunni-reakcii-pri-virusni-infekcii"/>
  <lastmod>2020-11-18T19:47:15+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/konferencia-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/konferencia-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/godisna-sresa-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/godisna-sresa-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-ose-danni-ot-sresata-po-problemite-na-cernia-drob-2010-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-ose-danni-ot-sresata-po-problemite-na-cernia-drob-2010-g"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-dekemvri-2010</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-dekemvri-2010"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2011-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2011-godina"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2011"/>
  <lastmod>2018-05-12T15:08:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2011-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2011-godina"/>
  <lastmod>2018-06-01T21:47:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-anuari-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-anuari-2011"/>
  <lastmod>2018-06-01T10:26:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/konferencia-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-0</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/konferencia-na-amerikanskata-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-0"/>
  <lastmod>2018-05-31T16:09:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2011"/>
  <lastmod>2018-06-01T21:46:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-fevruari-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-fevruari-2011"/>
  <lastmod>2018-06-01T21:46:20+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vitamin-d-i-cerniat-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vitamin-d-i-cerniat-drob"/>
  <lastmod>2018-06-24T17:16:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2011"/>
  <lastmod>2018-06-01T21:44:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mai-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mai-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uni-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uni-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uli-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uli-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-avgust-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-avgust-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-septemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-septemvri-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mart-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mart-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-april-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-april-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-ot-easl-2011-mai-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-ot-easl-2011-mai-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/easl-2011-lekarstva-za-lecenie-na-hcv-v-proces-na-razrabotka-predstaveni-na-konferenciata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/easl-2011-lekarstva-za-lecenie-na-hcv-v-proces-na-razrabotka-predstaveni-na-konferenciata"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-uni-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-uni-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-uli-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-uli-2011"/>
  <lastmod>2018-04-27T17:06:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-avgust-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-avgust-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-septemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-septemvri-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/cernodrobna-transplantacia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/cernodrobna-transplantacia"/>
  <lastmod>2018-06-25T07:11:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/cernodrobna-transplantacia-povtorna-poava-i-lecenie-na-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/cernodrobna-transplantacia-povtorna-poava-i-lecenie-na-hcv"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/lecenie-na-hepatit-c-kak-da-se-spravim-s-rezistentnostta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/lecenie-na-hepatit-c-kak-da-se-spravim-s-rezistentnostta"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/easl-2011-izlekuvane-bez-interferonribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/easl-2011-izlekuvane-bez-interferonribavirin"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-oktomvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-oktomvri-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-oktomvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-oktomvri-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-noemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-noemvri-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nasoki-na-aasld-za-dobra-klinicna-praktika-pri-nsv-genotip-1-aktualizacia-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nasoki-na-aasld-za-dobra-klinicna-praktika-pri-nsv-genotip-1-aktualizacia-2011"/>
  <lastmod>2018-04-27T17:06:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-ot-aasld-2011-dekemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-ot-aasld-2011-dekemvri-2011"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2011-hcv-obzor</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2011-hcv-obzor"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2011-reportaz-posveten-na-hbv-sesiite-ot-konferenciata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2011-reportaz-posveten-na-hbv-sesiite-ot-konferenciata"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2011"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2012-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2012-godina"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2012"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2012-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2012-godina"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-anuari-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-anuari-2012"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nasoki-na-easl-za-dobra-klinicna-praktika-upravlenie-na-infekciata-s-virusa-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nasoki-na-easl-za-dobra-klinicna-praktika-upravlenie-na-infekciata-s-virusa-na-hepatit-c"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-v-trsene-na-dobavki-1-va-cast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-v-trsene-na-dobavki-1-va-cast"/>
  <lastmod>2018-05-31T16:08:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/mozcna-mgla-vsicko-e-v-glavata-ti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/mozcna-mgla-vsicko-e-v-glavata-ti"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-fevruari-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-fevruari-2012"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2012"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2012"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mart-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mart-2012"/>
  <lastmod>2018-05-12T15:41:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-v-trsene-na-dobavki-2-ra-cast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-v-trsene-na-dobavki-2-ra-cast"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/devet-prosti-nacina-za-podsilvane-stimulirane-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/devet-prosti-nacina-za-podsilvane-stimulirane-na-cernia-drob"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-c-pregled-paracetamol-acetaminofen-tilenol</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-c-pregled-paracetamol-acetaminofen-tilenol"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-april-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-april-2012"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2012"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mai-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mai-2012"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mai-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mai-2012"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uni-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uni-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-uni-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-uni-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-silata-na-grupite-za-podkrepa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-silata-na-grupite-za-podkrepa"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-uli-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-uli-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-uli-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-uli-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-avgust-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-avgust-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-avgust-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-avgust-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-polezni-sveti-ot-pacienti-za-lecenie-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-polezni-sveti-ot-pacienti-za-lecenie-na-hepatit-c"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/igrata-na-izcakvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/igrata-na-izcakvane"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-septemvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-septemvri-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-septemvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-septemvri-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-sled-kato-prikluci-lecenieto-na-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-sled-kato-prikluci-lecenieto-na-hcv"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/napredkt-pri-transplantaciata-na-ceren-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/napredkt-pri-transplantaciata-na-ceren-drob"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-oktomvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-oktomvri-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-oktomvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-oktomvri-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/diabet-tip-2-i-insulinova-rezistentnost-pri-hora-s-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/diabet-tip-2-i-insulinova-rezistentnost-pri-hora-s-hcv"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-noemvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-noemvri-2012"/>
  <lastmod>2018-05-12T15:12:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2012"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nasoki-na-easl-za-dobra-klinicna-praktika-upravlenie-na-hronicnata-infekcia-s-virusa-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nasoki-na-easl-za-dobra-klinicna-praktika-upravlenie-na-hronicnata-infekcia-s-virusa-na"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-dekemvri-2012-aasld-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-dekemvri-2012-aasld-2012"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2012"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2013-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2013-godina"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2013-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2013-godina"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-anuari-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-anuari-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/amerikanska-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2012-terapii-za-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/amerikanska-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2012-terapii-za-hcv"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/recenzia-na-izsledvaneto-proucvane-na-partnora</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/recenzia-na-izsledvaneto-proucvane-na-partnora"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-fevruari-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-fevruari-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mart-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mart-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/trainiat-virusologicen-otgovor-svr-vodi-do-podobravane-na-kognitivnite-funkcii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/trainiat-virusologicen-otgovor-svr-vodi-do-podobravane-na-kognitivnite-funkcii"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-konferencia-po-retrovirusi-i-oportunisticni-infekcii-croi-2013-april-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-konferencia-po-retrovirusi-i-oportunisticni-infekcii-croi-2013-april-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/upotrebata-na-alkohol-i-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/upotrebata-na-alkohol-i-hepatit-c"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mai-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mai-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mai-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mai-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-denat-na-maikata-v-sankata-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-denat-na-maikata-v-sankata-na-hepatit-s"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2014-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2014-godina"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-top-novini-2013</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-top-novini-2013"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-anuari-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-anuari-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2013-toksicnia-efekt-na-paracetamola</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2013-toksicnia-efekt-na-paracetamola"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-mart-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-mart-2014"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-april-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-april-2014"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2013-dlgosrocna-prezivaemost-na-cernodrobnata-fibroza-sled-virusologicno-izlekuvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2013-dlgosrocna-prezivaemost-na-cernodrobnata-fibroza-sled-virusologicno-izlekuvane"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2013-tenofovir-za-hepatit-v-prodlzava-da-e-bezopasen-i-efektiven-i-sled-7-godini</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2013-tenofovir-za-hepatit-v-prodlzava-da-e-bezopasen-i-efektiven-i-sled-7-godini"/>
  <lastmod>2018-05-31T16:07:20+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/moze-li-da-pomogne-kafeto-za-predotvratavane-na-cernodrobnata-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/moze-li-da-pomogne-kafeto-za-predotvratavane-na-cernodrobnata-fibroza"/>
  <lastmod>2018-05-28T15:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kolko-dlgo-ocelava-virust-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kolko-dlgo-ocelava-virust-na-hepatit-s"/>
  <lastmod>2018-06-24T17:03:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zdravoslovno-novite-lekarstva-za-hepatit-c-razocarovanie-ili-nadezda</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zdravoslovno-novite-lekarstva-za-hepatit-c-razocarovanie-ili-nadezda"/>
  <lastmod>2018-05-12T15:12:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/lekarstva-za-lecenie-na-hepatit-b-i-s-odobreni-i-v-proces-na-razrabotka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/lekarstva-za-lecenie-na-hepatit-b-i-s-odobreni-i-v-proces-na-razrabotka"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/koi-sa-lekarstvata-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/koi-sa-lekarstvata-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/koi-lekarstva-sa-bezopasni-pri-lecenie-na-hepatit-v-i-s-po-vreme-na-bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/koi-lekarstva-sa-bezopasni-pri-lecenie-na-hepatit-v-i-s-po-vreme-na-bremennost"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-noemvri-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-noemvri-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-obzor-fevruari-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-obzor-fevruari-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-noemvri-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-noemvri-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2014"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-anuari-2015-obzor-na-top-novinite-ot-2014-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-anuari-2015-obzor-na-top-novinite-ot-2014-g"/>
  <lastmod>2018-05-12T15:13:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-anuari-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-anuari-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kafeto-i-caat-moze-da-pomognat-za-namalavane-vzpalenieto-na-cernia-drob-pri-hora-s-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kafeto-i-caat-moze-da-pomognat-za-namalavane-vzpalenieto-na-cernia-drob-pri-hora-s-hepatit"/>
  <lastmod>2018-06-21T12:45:23+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2013-virusniat-hepatit-e-vodesa-pricina-za-smrt-v-svetoven-masab</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2013-virusniat-hepatit-e-vodesa-pricina-za-smrt-v-svetoven-masab"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/aasld-2013-tenofovir-alafenamid-ima-shodno-anti-hbv-deistvie-s-po-malka-bbrecna-toksicnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/aasld-2013-tenofovir-alafenamid-ima-shodno-anti-hbv-deistvie-s-po-malka-bbrecna-toksicnost"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-dekemvri-2014</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-dekemvri-2014"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/seksualnoto-predavane-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/seksualnoto-predavane-na-hepatit-s"/>
  <lastmod>2018-06-21T08:18:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-2015-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-2015-godina"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-fevruari-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-fevruari-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-2015-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-2015-godina"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-fevruari-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-fevruari-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-mart-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-mart-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-mart-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-mart-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hbv-journal-april-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hbv-journal-april-2015"/>
  <lastmod>2018-05-12T15:13:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-april-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-april-2015"/>
  <lastmod>2019-12-29T12:37:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-aktualnoto-lechenie-na-khepatit-s-kratki-fakti-2015-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-aktualnoto-lechenie-na-khepatit-s-kratki-fakti-2015-g"/>
  <lastmod>2019-12-29T12:37:12+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-may-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-may-2015"/>
  <lastmod>2019-12-29T12:36:42+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hbv-journal-may-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hbv-journal-may-2015"/>
  <lastmod>2019-12-29T12:35:24+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hbv-journal-yuni-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hbv-journal-yuni-2015"/>
  <lastmod>2019-12-29T12:34:52+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-yuli-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-yuli-2015"/>
  <lastmod>2019-12-29T12:33:54+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-yuni-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-yuni-2015"/>
  <lastmod>2019-12-29T12:32:54+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hcv-journal-avgust-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hcv-journal-avgust-2015"/>
  <lastmod>2019-12-29T12:32:13+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-septemvri-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-septemvri-2015"/>
  <lastmod>2019-12-29T12:31:43+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-oktomvri-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-oktomvri-2015"/>
  <lastmod>2019-12-29T12:31:09+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-po-vazhnite-novini-za-khepatit-v-noemvri-2015-1-va-chast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-po-vazhnite-novini-za-khepatit-v-noemvri-2015-1-va-chast"/>
  <lastmod>2019-12-29T12:30:45+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-noemvri-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-noemvri-2015"/>
  <lastmod>2019-12-29T12:29:33+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-dekemvri-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-dekemvri-2015"/>
  <lastmod>2019-12-29T12:29:08+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-po-interesnite-novini-za-khepatit-v-dekemvri-2015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-po-interesnite-novini-za-khepatit-v-dekemvri-2015"/>
  <lastmod>2019-12-29T12:27:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-yanuari-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-yanuari-2016"/>
  <lastmod>2019-12-29T12:26:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-fevruari-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-zhurnal-fevruari-2016"/>
  <lastmod>2019-12-29T12:26:16+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-predavane-na-khepatit-v-pri-bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-predavane-na-khepatit-v-pri-bremennost"/>
  <lastmod>2019-12-29T12:25:47+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-mart-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-hcv-journal-mart-2016"/>
  <lastmod>2019-12-29T12:24:51+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-podbrani-novini-za-khepatit-v-yanuari-april-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-podbrani-novini-za-khepatit-v-yanuari-april-2016"/>
  <lastmod>2019-12-29T12:24:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-c-predavane-i-prevencia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-c-predavane-i-prevencia"/>
  <lastmod>2018-06-21T12:44:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-upravlenie-na-stranichnite-efekti-ot-lechenieto-na-khepatit-c-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-upravlenie-na-stranichnite-efekti-ot-lechenieto-na-khepatit-c-hcv"/>
  <lastmod>2019-12-29T12:21:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/ostriat-hepatit-moze-da-bde-svrzan-s-konsumaciata-na-energiini-napitki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/ostriat-hepatit-moze-da-bde-svrzan-s-konsumaciata-na-energiini-napitki"/>
  <lastmod>2018-06-15T17:23:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-aktualni-razrabotvani-hcv-lekarstva-noemvri-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-aktualni-razrabotvani-hcv-lekarstva-noemvri-2016"/>
  <lastmod>2019-12-29T12:36:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kak-pomagame</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kak-pomagame"/>
  <lastmod>2026-08-07T11:50:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/koinfekciya-na-khepatit-v-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/koinfekciya-na-khepatit-v-i-khepatit-s"/>
  <lastmod>2019-12-29T08:35:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nai-vaznoto-za-hepatit-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nai-vaznoto-za-hepatit-d"/>
  <lastmod>2018-06-15T15:12:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nova-klasifikaciya-pri-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nova-klasifikaciya-pri-khepatit-v"/>
  <lastmod>2020-11-18T19:38:16+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/iziskvania-za-lecenie-na-pacienti-pod-18-g-s-hepatit-v-c-ili-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/iziskvania-za-lecenie-na-pacienti-pod-18-g-s-hepatit-v-c-ili-d"/>
  <lastmod>2018-12-19T18:57:21+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/iziskvaniya-na-nzok-za-lechenie-na-khronichen-khepatit-s-nad-18-godishna-vzrast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/iziskvaniya-na-nzok-za-lechenie-na-khronichen-khepatit-s-nad-18-godishna-vzrast"/>
  <lastmod>2026-02-19T13:59:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/iziskvaniya-za-lechenie-na-pacienti-nad-18-g-s-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/iziskvaniya-za-lechenie-na-pacienti-nad-18-g-s-khepatit-v"/>
  <lastmod>2026-02-19T13:58:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/avtoimunniyat-khepatit-nakratko</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/avtoimunniyat-khepatit-nakratko"/>
  <lastmod>2019-12-29T08:34:12+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kratka-informaciya-za-khepatit-v-pri-bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kratka-informaciya-za-khepatit-v-pri-bremennost"/>
  <lastmod>2019-12-29T08:35:06+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-kakvo-e-da-se-lekuvash-s-bezinterferonova-terapiya-opitt-na-prviya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-kakvo-e-da-se-lekuvash-s-bezinterferonova-terapiya-opitt-na-prviya"/>
  <lastmod>2019-12-29T12:34:41+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/terminologiata-v-klinicnite-izpitvania-i-medicinskata-literatura</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/terminologiata-v-klinicnite-izpitvania-i-medicinskata-literatura"/>
  <lastmod>2018-06-20T21:21:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/natrupvane-na-zelazo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/natrupvane-na-zelazo"/>
  <lastmod>2018-06-19T13:10:53+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hepatit-s-i-tatuirovkite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hepatit-s-i-tatuirovkite"/>
  <lastmod>2018-06-19T13:11:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-prevenciya-na-predavaneto-na-hcv-pri-razkrasyavaschi-proceduri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-prevenciya-na-predavaneto-na-hcv-pri-razkrasyavaschi-proceduri"/>
  <lastmod>2019-12-29T12:19:00+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/strest-i-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/strest-i-cernia-drob"/>
  <lastmod>2018-06-21T13:40:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/mozchna-mgla-pri-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/mozchna-mgla-pri-khepatit-s"/>
  <lastmod>2019-12-29T12:16:43+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kakvo-e-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kakvo-e-ciroza"/>
  <lastmod>2018-06-20T21:36:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kakvo-e-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kakvo-e-fibroza"/>
  <lastmod>2018-06-20T21:34:00+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/khepatit-kakvo-tryabva-da-znaete-za-nego</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/khepatit-kakvo-tryabva-da-znaete-za-nego"/>
  <lastmod>2019-12-29T12:15:39+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/arkhivna-statiya-khepatit-b-chesto-zadavani-vprosi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/arkhivna-statiya-khepatit-b-chesto-zadavani-vprosi"/>
  <lastmod>2019-12-29T12:18:14+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kak-da-razchetem-izsledvaniyata-si-za-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kak-da-razchetem-izsledvaniyata-si-za-khepatit-v"/>
  <lastmod>2023-01-09T11:46:40+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/rak-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/rak-na-cernia-drob"/>
  <lastmod>2018-06-21T11:02:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kak-da-razchetem-izsledvaniyata-si-za-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kak-da-razchetem-izsledvaniyata-si-za-khepatit-s"/>
  <lastmod>2023-01-26T14:44:12+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/provedohme-dvudneven-skrining-za-hepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/provedohme-dvudneven-skrining-za-hepatit-v-i-s"/>
  <lastmod>2018-06-24T19:12:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/provedohme-dvudneven-skrining-za-hepatit-v-i-s-0</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/provedohme-dvudneven-skrining-za-hepatit-v-i-s-0"/>
  <lastmod>2018-06-24T19:12:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/dvudneven-skrining-za-hepatit-v-i-s-sred-akuser-ginekolozi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/dvudneven-skrining-za-hepatit-v-i-s-sred-akuser-ginekolozi"/>
  <lastmod>2018-06-24T19:19:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nalichni-medikamenti-za-lechenie-na-khepatit-s-v-blgariya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nalichni-medikamenti-za-lechenie-na-khepatit-s-v-blgariya"/>
  <lastmod>2025-11-02T08:10:13+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/prvicen-biliaren-holangit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/prvicen-biliaren-holangit"/>
  <lastmod>2019-01-15T17:43:12+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bolest-na-uilsn</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bolest-na-uilsn"/>
  <lastmod>2019-01-15T19:33:14+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/hemohromatoza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/hemohromatoza"/>
  <lastmod>2019-01-15T19:45:43+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/spiraneto-na-oralnata-antivirusna-terapiya-pri-hronichen-hepatit-b-e-v%D1%83zmozhno-za-nyakoi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/spiraneto-na-oralnata-antivirusna-terapiya-pri-hronichen-hepatit-b-e-v%D1%83zmozhno-za-nyakoi"/>
  <lastmod>2019-12-29T08:19:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/vliyae-li-maychinata-infekciya-s-hcv-vrkhu-tegloto-na-bliznacite-pri-razhdane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/vliyae-li-maychinata-infekciya-s-hcv-vrkhu-tegloto-na-bliznacite-pri-razhdane"/>
  <lastmod>2019-12-29T08:24:32+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/predizvikatelstva-pri-prevenciya-predavaneto-na-virusa-na-khepatit-s-ot-mayka-na-dete</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/predizvikatelstva-pri-prevenciya-predavaneto-na-virusa-na-khepatit-s-ot-mayka-na-dete"/>
  <lastmod>2019-12-29T08:24:22+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nalichni-medikamenti-za-lechenie-na-khepatit-v-v-blgariya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nalichni-medikamenti-za-lechenie-na-khepatit-v-v-blgariya"/>
  <lastmod>2025-11-02T08:17:53+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/checkpoint-sofiya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/checkpoint-sofiya"/>
  <lastmod>2020-11-24T17:05:45+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/spring-bank-spirat-klinichnoto-prouchvane-na-medikament-za-lechenie-na-khronichen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/spring-bank-spirat-klinichnoto-prouchvane-na-medikament-za-lechenie-na-khronichen-khepatit"/>
  <lastmod>2020-09-15T09:44:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kakvo-da-vklyuchite-v-menyuto-si-ako-imate-omaznen-cheren-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kakvo-da-vklyuchite-v-menyuto-si-ako-imate-omaznen-cheren-drob"/>
  <lastmod>2020-05-11T12:10:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/nealkokholni-mastni-zabolyavaniya-na-cherniya-drob-nafld-i-nash</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/nealkokholni-mastni-zabolyavaniya-na-cherniya-drob-nafld-i-nash"/>
  <lastmod>2020-09-12T10:48:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/imam-hepatit-no-nyamam-zdravni-osigurovki-moga-li-da-se-lekuvam</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/imam-hepatit-no-nyamam-zdravni-osigurovki-moga-li-da-se-lekuvam"/>
  <lastmod>2020-06-15T10:22:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sdruzhenie-hepaktiv-svikva-obshto-sybranie-na-22102020</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sdruzhenie-hepaktiv-svikva-obshto-sybranie-na-22102020"/>
  <lastmod>2020-09-15T09:06:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/8-godini-neuspeshni-opiti-za-szdavane-na-nacionalna-programa-za-kontrol-i-prevenciya-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/8-godini-neuspeshni-opiti-za-szdavane-na-nacionalna-programa-za-kontrol-i-prevenciya-na"/>
  <lastmod>2020-11-21T14:55:27+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/informacionna-broshura-za-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/informacionna-broshura-za-khepatit-v"/>
  <lastmod>2021-07-04T11:35:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/informacionna-broshura-za-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/informacionna-broshura-za-khepatit-s"/>
  <lastmod>2021-07-04T11:37:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sdruzhenie-khepaktiv-svikva-obscho-sbranie-na-21-septemvri-2021g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sdruzhenie-khepaktiv-svikva-obscho-sbranie-na-21-septemvri-2021g"/>
  <lastmod>2021-07-12T17:24:37+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kakvo-predstavlyava-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kakvo-predstavlyava-khepatit-s"/>
  <lastmod>2021-11-15T11:58:51+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/zhivot-s-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/zhivot-s-khepatit-s"/>
  <lastmod>2021-11-15T12:06:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/obschnostta-govori-edin-den-ot-zhivota-s-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/obschnostta-govori-edin-den-ot-zhivota-s-khepatit-s"/>
  <lastmod>2021-11-15T12:13:59+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sdruzhenie-khepaktiv-svikva-obscho-sbranie-na-21-septemvri-2022g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sdruzhenie-khepaktiv-svikva-obscho-sbranie-na-21-septemvri-2022g"/>
  <lastmod>2022-08-16T16:39:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/otbelyazvame-evropeyskata-testing-sedmica-za-virusni-khepatiti-khiv-i-spi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/otbelyazvame-evropeyskata-testing-sedmica-za-virusni-khepatiti-khiv-i-spi"/>
  <lastmod>2023-05-15T14:35:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/sdruzhenie-Hepactive-svikva-OS-2023</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/sdruzhenie-Hepactive-svikva-OS-2023"/>
  <lastmod>2023-08-22T17:31:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/imate-li-srbezh-svrzan-s-PBC</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/imate-li-srbezh-svrzan-s-PBC"/>
  <lastmod>2023-12-02T10:21:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/kde-da-namerite-hepatect-cp</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/kde-da-namerite-hepatect-cp"/>
  <lastmod>2024-01-31T12:55:19+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/bepirovirsen-poluchi-zelena-svetlina-za-prodlzhavane-na-klinichnite-izpitvaniya-za-lechenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/bepirovirsen-poluchi-zelena-svetlina-za-prodlzhavane-na-klinichnite-izpitvaniya-za-lechenie"/>
  <lastmod>2024-02-14T10:58:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/OS2024</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/OS2024"/>
  <lastmod>2024-08-19T08:39:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-23-septemvri-2025</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-23-septemvri-2025"/>
  <lastmod>2025-08-12T07:33:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-sdruzhenie-khepaktiv-na-11-septemvri-2026g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-sdruzhenie-khepaktiv-na-11-septemvri-2026g"/>
  <lastmod>2026-08-07T09:57:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-sdruzhenie-khepaktiv-na-11-septemvri-2026-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/article/svikvane-na-obscho-sbranie-na-sdruzhenie-khepaktiv-na-11-septemvri-2026-g"/>
  <lastmod>2026-08-07T10:18:37+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/grizhata-za-zdraveto-ne-poznava-vzrast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/grizhata-za-zdraveto-ne-poznava-vzrast"/>
  <lastmod>2019-03-01T08:39:15+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/bezplatni-izsledvania-za-hepatit-v-i-s-v-grad-smolan</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/bezplatni-izsledvania-za-hepatit-v-i-s-v-grad-smolan"/>
  <lastmod>2018-07-24T20:20:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/sksai-s-hepatita-na-28-uli</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/sksai-s-hepatita-na-28-uli"/>
  <lastmod>2018-07-27T09:30:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/ela-na-6-i-7-oktomvri-na-bulgaria-tattoo-expo-i-se-izsledvai-bezplatno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/ela-na-6-i-7-oktomvri-na-bulgaria-tattoo-expo-i-se-izsledvai-bezplatno"/>
  <lastmod>2018-09-26T11:23:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/konkurs-za-zurnalisticeski-material-na-tema-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/konkurs-za-zurnalisticeski-material-na-tema-hepatit-c"/>
  <lastmod>2018-12-08T08:30:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/evropeiska-sedmica-za-testvane-za-hiv-i-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/evropeiska-sedmica-za-testvane-za-hiv-i-hepatit"/>
  <lastmod>2018-11-22T20:21:09+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/novata-ni-broshura-za-hepatit-b-e-tuk</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/novata-ni-broshura-za-hepatit-b-e-tuk"/>
  <lastmod>2019-02-26T17:16:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/izsledvay-se-po-vreme-na-proletnata-sedmica-za-testvane-za-khiv-i-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/izsledvay-se-po-vreme-na-proletnata-sedmica-za-testvane-za-khiv-i-khepatit"/>
  <lastmod>2019-05-16T21:15:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/24-yuli-trgovische-bezplatni-izsledvaniya-za-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/24-yuli-trgovische-bezplatni-izsledvaniya-za-khepatit-v-i-s"/>
  <lastmod>2019-07-18T09:39:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/25-yuli-razgrad-bezplatni-izsledvaniya-za-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/25-yuli-razgrad-bezplatni-izsledvaniya-za-khepatit-v-i-s"/>
  <lastmod>2019-07-18T09:39:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/26-yuli-varna-bezplatni-izsledvaniya-za-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/26-yuli-varna-bezplatni-izsledvaniya-za-khepatit-v-i-s"/>
  <lastmod>2019-07-18T09:39:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/28-yuli-svetoven-den-za-borba-s-khepatita-ela-i-se-izsledvay</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/28-yuli-svetoven-den-za-borba-s-khepatita-ela-i-se-izsledvay"/>
  <lastmod>2019-12-13T11:30:03+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/checkpoint-sofiya-otbelyazva-proletnata-evropeyska-sedmica-za-testvane-za-khiv-i-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/checkpoint-sofiya-otbelyazva-proletnata-evropeyska-sedmica-za-testvane-za-khiv-i-khepatit"/>
  <lastmod>2020-05-16T10:56:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/svetli-velikdenski-praznici</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/svetli-velikdenski-praznici"/>
  <lastmod>2024-04-22T08:16:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-se-predpazim</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-se-predpazim"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/do-kakvo-moze-da-dovede-virusnia-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/do-kakvo-moze-da-dovede-virusnia-hepatit"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-razbera-dali-imam-virusen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-razbera-dali-imam-virusen-khepatit"/>
  <lastmod>2021-01-28T14:00:57+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvi-sa-nacinite-na-zarazavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvi-sa-nacinite-na-zarazavane"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakva-e-celta-pri-lecenie-na-hronicen-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakva-e-celta-pri-lecenie-na-hronicen-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ot-kde-se-poavavat-hepatitnite-virusi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ot-kde-se-poavavat-hepatitnite-virusi"/>
  <lastmod>2018-05-12T14:58:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-hepatitnite-virusi-uvrezdat-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-hepatitnite-virusi-uvrezdat-cernia-drob"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-reagira-organizma-na-covek-pri-zarazavane-s-hepatiten-virus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-reagira-organizma-na-covek-pri-zarazavane-s-hepatiten-virus"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvi-sa-nai-opasnite-posledstvia-ot-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvi-sa-nai-opasnite-posledstvia-ot-hepatita"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kolko-dlgo-moze-da-prodlzi-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kolko-dlgo-moze-da-prodlzi-hepatita"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hepatit"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/moze-li-da-se-izlekuvam-ot-hronicen-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/moze-li-da-se-izlekuvam-ot-hronicen-hepatit-c"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-da-ocakvame-pri-lecenie-na-hepatit-v-s-pegiliran-interferon</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-da-ocakvame-pri-lecenie-na-hepatit-v-s-pegiliran-interferon"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/trabva-li-vseki-s-hronicen-hepatit-v-da-se-lekuva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/trabva-li-vseki-s-hronicen-hepatit-v-da-se-lekuva"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/koi-sa-antivirusnite-preparati-za-lecenie-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/koi-sa-antivirusnite-preparati-za-lecenie-na-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-alat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-alat"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ostr-ili-hronicen-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ostr-ili-hronicen-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatitt-i-tatuirovkite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatitt-i-tatuirovkite"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-ostr-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-ostr-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/sekst-i-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/sekst-i-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-i-s-kakva-skorost-progresira-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-i-s-kakva-skorost-progresira-hepatit-s"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/strest-i-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/strest-i-cernia-drob"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-znaci-antigeni-i-antitela</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-znaci-antigeni-i-antitela"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-e-antigen-hbeag</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-e-antigen-hbeag"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/testt-vi-za-hepatit-v-e-polozitelen-sega-kakvo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/testt-vi-za-hepatit-v-e-polozitelen-sega-kakvo"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/cernodrobna-biopsia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/cernodrobna-biopsia"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hbeag-otricatelen-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hbeag-otricatelen-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ako-100-bebeta-biha-bili-zarazeni-s-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ako-100-bebeta-biha-bili-zarazeni-s-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/nvv-predavane-i-predpazvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/nvv-predavane-i-predpazvane"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-nvv-genotip</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-nvv-genotip"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/cernia-drob"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/koga-da-razkriete-ce-imate-nvv-infekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/koga-da-razkriete-ce-imate-nvv-infekcia"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ako-100-vzrastni-biha-bili-zarazeni-s-virusa-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ako-100-vzrastni-biha-bili-zarazeni-s-virusa-na-hepatit-v"/>
  <lastmod>2018-05-12T14:58:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hbv-dna-i-kak-se-izmerva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hbv-dna-i-kak-se-izmerva"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-b-i-alkohola</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-b-i-alkohola"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-afp</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-afp"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/predavane-ot-maika-na-dete</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/predavane-ot-maika-na-dete"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ostr-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ostr-hepatit-v"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/khepatit-kakvo-tryabva-da-znaete-za-nego</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/khepatit-kakvo-tryabva-da-znaete-za-nego"/>
  <lastmod>2021-01-28T14:25:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/upravlenie-na-stranicnite-efekti-pri-lecenie-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/upravlenie-na-stranicnite-efekti-pri-lecenie-na-hepatit-v"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-se-tlkuvat-testovete-za-antitela-i-virusnite-testove-pri-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-se-tlkuvat-testovete-za-antitela-i-virusnite-testove-pri-hepatit-v"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-fibroza-i-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-fibroza-i-ciroza"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/koi-medikamenti-za-lecenie-na-hepatit-v-trabva-da-se-izpolzvat-nai-napred</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/koi-medikamenti-za-lecenie-na-hepatit-v-trabva-da-se-izpolzvat-nai-napred"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kolko-cesto-trabva-da-se-nabludava-kontrolira-prosledava-hronicnia-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kolko-cesto-trabva-da-se-nabludava-kontrolira-prosledava-hronicnia-hepatit-v"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hbv-virusno-natovarvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hbv-virusno-natovarvane"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hepatit-b"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-se-tlkuvat-i-razbirat-cernodrobnite-testove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-se-tlkuvat-i-razbirat-cernodrobnite-testove"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hbv-predotvratavane-na-infekciata-maika-dete</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hbv-predotvratavane-na-infekciata-maika-dete"/>
  <lastmod>2018-06-19T13:36:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ocenka-na-histologicnata-aktivnost-pri-cernodrobnata-biopsia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ocenka-na-histologicnata-aktivnost-pri-cernodrobnata-biopsia"/>
  <lastmod>2018-06-19T13:37:20+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-v-koga-e-nuzno-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-v-koga-e-nuzno-lecenie"/>
  <lastmod>2018-05-12T14:58:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hepatit-b-0</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hepatit-b-0"/>
  <lastmod>2018-05-31T16:33:34+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-se-slucva-kogato-se-poavi-lekarstvena-rezistentnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-se-slucva-kogato-se-poavi-lekarstvena-rezistentnost"/>
  <lastmod>2018-05-31T16:33:14+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-b-cesto-zadavani-vprosi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-b-cesto-zadavani-vprosi"/>
  <lastmod>2018-06-19T14:07:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/prevencia-na-hepatit-b-v-ksi-i-pri-razkrasavasi-proceduri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/prevencia-na-hepatit-b-v-ksi-i-pri-razkrasavasi-proceduri"/>
  <lastmod>2018-05-31T16:32:34+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-v-antigen-i-antitalo-testove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-v-antigen-i-antitalo-testove"/>
  <lastmod>2018-06-19T14:08:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-v-cernodrobna-biopsia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-v-cernodrobna-biopsia"/>
  <lastmod>2018-06-19T14:09:34+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvi-sa-profesionalnite-riskove-pri-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvi-sa-profesionalnite-riskove-pri-hepatit-b"/>
  <lastmod>2018-05-31T16:30:31+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-kazem-na-decata-ce-imat-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-kazem-na-decata-ce-imat-hepatit-b"/>
  <lastmod>2018-06-19T13:26:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-v-i-hcv-koinfekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-v-i-hcv-koinfekcia"/>
  <lastmod>2018-05-31T16:29:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/lekarstva-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/lekarstva-za-hepatit-s"/>
  <lastmod>2018-05-31T16:29:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/nepreksnata-terapia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/nepreksnata-terapia"/>
  <lastmod>2018-05-31T16:29:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/lecenie-na-hepatit-c-interferon-i-ribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/lecenie-na-hepatit-c-interferon-i-ribavirin"/>
  <lastmod>2018-05-31T16:29:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/test-za-antitela-za-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/test-za-antitela-za-hepatit-c"/>
  <lastmod>2018-05-31T16:29:05+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/test-za-virusno-natovarvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/test-za-virusno-natovarvane"/>
  <lastmod>2018-05-31T16:28:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-hcv-genotip</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-hcv-genotip"/>
  <lastmod>2018-05-31T16:28:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/metadon-i-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/metadon-i-hcv"/>
  <lastmod>2018-05-31T16:28:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/snat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/snat"/>
  <lastmod>2018-05-31T16:28:14+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/desette-nai-vazni-zdravoslovni-navika</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/desette-nai-vazni-zdravoslovni-navika"/>
  <lastmod>2018-05-31T16:27:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/ako-100-coveka-sa-infektirani-s-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/ako-100-coveka-sa-infektirani-s-hepatit-s"/>
  <lastmod>2018-05-31T16:27:14+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/alkoholt-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/alkoholt-i-hepatit-s"/>
  <lastmod>2018-05-31T16:27:05+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/testove-za-hcv-virusno-natovarvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/testove-za-hcv-virusno-natovarvane"/>
  <lastmod>2018-06-19T13:20:10+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/vprosi-koito-da-zadadete-na-vasia-lekuvas-lekar</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/vprosi-koito-da-zadadete-na-vasia-lekuvas-lekar"/>
  <lastmod>2018-05-23T09:28:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-razcetem-laboratornite-si-izsledvania</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-razcetem-laboratornite-si-izsledvania"/>
  <lastmod>2018-05-23T10:02:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/novi-antivirusni-lekarstva-za-hcv-i-lekarstvena-rezistentnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/novi-antivirusni-lekarstva-za-hcv-i-lekarstvena-rezistentnost"/>
  <lastmod>2018-05-31T16:25:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/obzor-na-diagnosticnite-testove-za-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/obzor-na-diagnosticnite-testove-za-hcv"/>
  <lastmod>2018-05-23T10:00:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/predskazvasi-faktori-za-otgovora-na-lecenieto-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/predskazvasi-faktori-za-otgovora-na-lecenieto-na-hepatit-c"/>
  <lastmod>2018-05-31T16:26:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-ciroza"/>
  <lastmod>2018-05-31T16:25:13+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/pirsing-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/pirsing-i-hepatit-s"/>
  <lastmod>2018-05-31T16:25:00+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/zarazavane-s-hepatit-c-crez-izpolzvane-na-edna-i-ssa-igla</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/zarazavane-s-hepatit-c-crez-izpolzvane-na-edna-i-ssa-igla"/>
  <lastmod>2018-05-31T16:24:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/higiena-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/higiena-i-hepatit-s"/>
  <lastmod>2018-05-31T16:24:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/dieta-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/dieta-i-hepatit-s"/>
  <lastmod>2018-05-31T16:24:32+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/bilkite-i-vitaminite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/bilkite-i-vitaminite"/>
  <lastmod>2018-05-31T16:24:23+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/prirodna-i-alternativna-medicina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/prirodna-i-alternativna-medicina"/>
  <lastmod>2018-05-31T16:23:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/polozitelnite-strani-na-otkazvaneto-ot-cigarite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/polozitelnite-strani-na-otkazvaneto-ot-cigarite"/>
  <lastmod>2018-05-31T16:15:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/fakti-i-legendi-za-puseneto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/fakti-i-legendi-za-puseneto"/>
  <lastmod>2018-05-31T16:15:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/polezni-sveti-za-otkazvaneto-ot-cigarite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/polezni-sveti-za-otkazvaneto-ot-cigarite"/>
  <lastmod>2018-05-31T16:14:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/alkoholt-i-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/alkoholt-i-cernia-drob"/>
  <lastmod>2018-05-31T16:23:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/alkoholt-i-hepatit-s-0</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/alkoholt-i-hepatit-s-0"/>
  <lastmod>2018-05-23T11:46:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kak-da-se-oceni-dadeno-klinicno-izpitvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kak-da-se-oceni-dadeno-klinicno-izpitvane"/>
  <lastmod>2018-05-23T11:52:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/tipove-interferon-i-kak-rabotyat-te</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/tipove-interferon-i-kak-rabotyat-te"/>
  <lastmod>2019-03-13T14:35:26+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/termini-za-otgovor-na-lecenieto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/termini-za-otgovor-na-lecenieto"/>
  <lastmod>2018-05-23T12:06:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/neinvanzivni-markeri-za-cernodrobna-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/neinvanzivni-markeri-za-cernodrobna-fibroza"/>
  <lastmod>2018-05-23T12:26:10+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-e-steatoza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-e-steatoza"/>
  <lastmod>2018-05-23T12:28:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/progresia-na-zabolavaneto-steatoza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/progresia-na-zabolavaneto-steatoza"/>
  <lastmod>2018-05-23T12:32:53+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-diagnosticni-instrumenti-genotipi-podtipove-i-kvazividove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-diagnosticni-instrumenti-genotipi-podtipove-i-kvazividove"/>
  <lastmod>2018-05-23T13:02:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/bilki-i-hepatit-c-vtoro-izdanie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/bilki-i-hepatit-c-vtoro-izdanie"/>
  <lastmod>2018-06-19T13:20:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/progresia-na-zabolavaneto-kakvo-e-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/progresia-na-zabolavaneto-kakvo-e-ciroza"/>
  <lastmod>2018-06-19T13:24:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/poredica-uelnes-s-nsv-kontrolirane-na-cesto-sresani-simptomi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/poredica-uelnes-s-nsv-kontrolirane-na-cesto-sresani-simptomi"/>
  <lastmod>2018-06-19T13:21:14+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/poredica-uelnes-s-nsv-namalavane-na-stresa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/poredica-uelnes-s-nsv-namalavane-na-stresa"/>
  <lastmod>2018-06-19T13:21:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/poredica-uelnes-s-nsv-vaksinirane-sresu-grip</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/poredica-uelnes-s-nsv-vaksinirane-sresu-grip"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/poredica-uelnes-s-nsv-mieneto-na-rcete-tova-e-osnovnoto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/poredica-uelnes-s-nsv-mieneto-na-rcete-tova-e-osnovnoto"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-da-razseem-mitovete-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-da-razseem-mitovete-za-hepatit-s"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-testt-mi-za-hepatit-s-e-polozitelen-sega-kakvo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-testt-mi-za-hepatit-s-e-polozitelen-sega-kakvo"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-lecenie-bremennost-kategorii-lekarstva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-lecenie-bremennost-kategorii-lekarstva"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/sled-kraa-na-lecenieto-na-hepatit-c-rkovodstvo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/sled-kraa-na-lecenieto-na-hepatit-c-rkovodstvo"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/za-semeistvoto-i-priatelite-grizata-za-nasia-blizk-s-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/za-semeistvoto-i-priatelite-grizata-za-nasia-blizk-s-hepatit-c"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/zakleimavane-i-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/zakleimavane-i-hepatit-c"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/predavane-na-hepatit-c-po-polov-pt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/predavane-na-hepatit-c-po-polov-pt"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-rkovodstvo-za-rabotodateli-i-kolegi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-obucenie-i-podkrepa-rkovodstvo-za-rabotodateli-i-kolegi"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kratka-istoria-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kratka-istoria-na-hepatit-s"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/progresia-na-zabolavaneto-kakvo-e-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/progresia-na-zabolavaneto-kakvo-e-fibroza"/>
  <lastmod>2018-06-19T13:25:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/rkovodstvo-kak-da-ziveem-zdravoslovno-s-nsv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/rkovodstvo-kak-da-ziveem-zdravoslovno-s-nsv"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hcv-predavane-i-predpazvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hcv-predavane-i-predpazvane"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/progresia-na-zabolavaneto-ostr-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/progresia-na-zabolavaneto-ostr-hepatit-c"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-v-dokladvane-na-stranicni-efekti-ot-lekarstvata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-v-dokladvane-na-stranicni-efekti-ot-lekarstvata"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/rkovodstvo-za-hepatit-s-vzemane-na-resenia-za-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/rkovodstvo-za-hepatit-s-vzemane-na-resenia-za-lecenie"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/vvedenie-v-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/vvedenie-v-cernia-drob"/>
  <lastmod>2018-06-19T13:15:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/pozitiven-rezultat-za-hepatit-s-ot-izsledvaneto-za-virusa-sega-kakvo-da-prava</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/pozitiven-rezultat-za-hepatit-s-ot-izsledvaneto-za-virusa-sega-kakvo-da-prava"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hepatit-s-osnovni-polozenia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hepatit-s-osnovni-polozenia"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/zivot-s-hepatit-s-upravlenie-na-osnovnite-simptomi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/zivot-s-hepatit-s-upravlenie-na-osnovnite-simptomi"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/rkovodstvo-za-hepatit-s-da-se-podgotvim-za-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/rkovodstvo-za-hepatit-s-da-se-podgotvim-za-lecenie"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/tatuirovki-i-nsv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/tatuirovki-i-nsv"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/kakvo-da-kazem-za-lecenieto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/kakvo-da-kazem-za-lecenieto"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/sekst-i-nsv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/sekst-i-nsv"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/preduprezdenie-otnosno-ribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/preduprezdenie-otnosno-ribavirin"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/hranene-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/hranene-i-hepatit-s"/>
  <lastmod>2018-05-12T14:49:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/predavane-na-virusa-ot-maikata-na-novorodenoto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/predavane-na-virusa-ot-maikata-na-novorodenoto"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/na-kogo-da-kaza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/na-kogo-da-kaza"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/zatlstal-ceren-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/zatlstal-ceren-drob"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/prevencia-na-nsv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/prevencia-na-nsv"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/profesionalna-ekspozicia-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/profesionalna-ekspozicia-na-hepatit-s"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/metadon-i-lecenie-na-nsv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/metadon-i-lecenie-na-nsv"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/imunnata-sistema</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/imunnata-sistema"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/da-se-cuvstvas-umoren</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/da-se-cuvstvas-umoren"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/virust-na-hepatit-c-i-doplvasata-alternativna-medicinabilki-i-dieticni-dobavki-da-napravim-po</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/virust-na-hepatit-c-i-doplvasata-alternativna-medicinabilki-i-dieticni-dobavki-da-napravim-po"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/cerniat-drob-paracetamol-i-vasia-ceren-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/cerniat-drob-paracetamol-i-vasia-ceren-drob"/>
  <lastmod>2018-06-19T13:02:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/lekarstva-v-proces-na-razrabotka-telaprevir-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/lekarstva-v-proces-na-razrabotka-telaprevir-telaprevir"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/lekarstva-v-proces-na-razrabotka-boceprevir-boceprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/lekarstva-v-proces-na-razrabotka-boceprevir-boceprevir"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/pred-kakvi-predizvikatelstva-e-izpraven-pacientt-s-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/pred-kakvi-predizvikatelstva-e-izpraven-pacientt-s-hepatit-s"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/faq/v-sila-vlizat-novi-pravila-ot-april-2016-vizte-koi-sa-te</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/faq/v-sila-vlizat-novi-pravila-ot-april-2016-vizte-koi-sa-te"/>
  <lastmod>2018-05-12T14:49:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/posledni-rezultati-ot-klinicnite-izpitania-na-boseprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/posledni-rezultati-ot-klinicnite-izpitania-na-boseprevir"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tutunopuseneto-moze-da-vlosi-cernodrobnata-fibroza-pri-pacienti-s-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tutunopuseneto-moze-da-vlosi-cernodrobnata-fibroza-pri-pacienti-s-hepatit-c"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/odobrenite-terapii-na-hepatit-v-v-evropa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/odobrenite-terapii-na-hepatit-v-v-evropa"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/infekciata-s-virusa-na-hepatit-c-moze-da-uvredi-i-drugi-organi-i-tkani</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/infekciata-s-virusa-na-hepatit-c-moze-da-uvredi-i-drugi-organi-i-tkani"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sredno-okolo-90-ot-bolnite-ot-hepatit-c-v-evropa-ne-znaat-ce-sa-bolni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sredno-okolo-90-ot-bolnite-ot-hepatit-c-v-evropa-ne-znaat-ce-sa-bolni"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-naucno-otkritie-moze-da-pomogne-da-se-szdade-vaksina-sresu-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-naucno-otkritie-moze-da-pomogne-da-se-szdade-vaksina-sresu-hepatit-c"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prodlzitelnoto-lecenie-s-interferon-moze-da-namali-riska-ot-rak-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prodlzitelnoto-lecenie-s-interferon-moze-da-namali-riska-ot-rak-na-cernia-drob"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-izsledvane-opredela-riska-ot-zarazavane-maika-bebe-s-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-izsledvane-opredela-riska-ot-zarazavane-maika-bebe-s-hepatit-c"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vertex-obavi-ce-zapocva-razrabotkata-na-naslednik-na-lekarstvoto-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vertex-obavi-ce-zapocva-razrabotkata-na-naslednik-na-lekarstvoto-telaprevir"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/oficialni-danni-ot-faza-2-na-klinicnite-izpitania-na-lekarstvoto-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/oficialni-danni-ot-faza-2-na-klinicnite-izpitania-na-lekarstvoto-telaprevir"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/schering-plough-iznese-danni-za-neino-lekarstvo-konkurent-na-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/schering-plough-iznese-danni-za-neino-lekarstvo-konkurent-na-telaprevir"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ocakvaniata-za-novoto-lekarstvo-telaprevir-vx-950-sa-golemi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ocakvaniata-za-novoto-lekarstvo-telaprevir-vx-950-sa-golemi"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telaprevir-ima-potencial-dori-i-pri-skraten-kurs-na-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telaprevir-ima-potencial-dori-i-pri-skraten-kurs-na-lecenie"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-naucno-otkritie-moze-da-dade-alternativa-na-cernodrobnata-biopsia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-naucno-otkritie-moze-da-dade-alternativa-na-cernodrobnata-biopsia"/>
  <lastmod>2018-05-12T15:42:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/puseneto-pri-hepatit-s-uvelicava-riska-ot-razvitie-na-cernodroben-rak</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/puseneto-pri-hepatit-s-uvelicava-riska-ot-razvitie-na-cernodroben-rak"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/8-lekarstva-za-hepatit-s-koito-davat-nadezda</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/8-lekarstva-za-hepatit-s-koito-davat-nadezda"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/gennite-mutacii-pri-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/gennite-mutacii-pri-hepatit-v"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/fda-odobri-razsireni-indikacii-za-kombinirana-terapia-s-peginterferon-pri-hronicen-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/fda-odobri-razsireni-indikacii-za-kombinirana-terapia-s-peginterferon-pri-hronicen-hepatit-s"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pharmasset-zapocva-prvo-klinicno-izpitanie-na-nsv-polimerazen-inhibitor-ot-vtora-generacia-psi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pharmasset-zapocva-prvo-klinicno-izpitanie-na-nsv-polimerazen-inhibitor-ot-vtora-generacia-psi"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/klinicno-izpitvane-na-probnaizpitvana-vaksina-za-hepatit-v-heplisav</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/klinicno-izpitvane-na-probnaizpitvana-vaksina-za-hepatit-v-heplisav"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izpolzvaneto-na-edni-i-ssi-instrumentioborudvane-ot-razlicni-lica-moze-da-dovede-do-epidemii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izpolzvaneto-na-edni-i-ssi-instrumentioborudvane-ot-razlicni-lica-moze-da-dovede-do-epidemii"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nuzdaat-li-se-ot-biopsia-hbeag-negativnite-pacienti-s-nisk-virusen-tovar</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nuzdaat-li-se-ot-biopsia-hbeag-negativnite-pacienti-s-nisk-virusen-tovar"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/znacenie-na-nivata-na-hbv-dna-pri-hora-s-hbeag-otricatelen-hronicen-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/znacenie-na-nivata-na-hbv-dna-pri-hora-s-hbeag-otricatelen-hronicen-hepatit-v"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-viread-e-efektiven-pri-pacienti-s-hronicen-hepatit-v-nezavisimo-ot-stadia-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-viread-e-efektiven-pri-pacienti-s-hronicen-hepatit-v-nezavisimo-ot-stadia-na"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/silimarint-podobrava-kacestvoto-na-coveskia-zivot-po-vreme-na-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/silimarint-podobrava-kacestvoto-na-coveskia-zivot-po-vreme-na-lecenieto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rezultati-ot-success-proucvaneto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rezultati-ot-success-proucvaneto"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/mzete-stradat-ot-seksualna-disfunkcia-po-vreme-na-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/mzete-stradat-ot-seksualna-disfunkcia-po-vreme-na-lecenieto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/genna-variacia-prognozira-uspeha-na-terapiata-pri-hronicen-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/genna-variacia-prognozira-uspeha-na-terapiata-pri-hronicen-hepatit-s"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dali-nivoto-na-hbv-virusnia-tovar-moze-da-predskaze-razvitieto-na-cernodrobnata-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dali-nivoto-na-hbv-virusnia-tovar-moze-da-predskaze-razvitieto-na-cernodrobnata-fibroza"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/esaas-nai-posle-zapocva-da-se-obrsa-vnimanie-na-virusa-na-hepatit-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/esaas-nai-posle-zapocva-da-se-obrsa-vnimanie-na-virusa-na-hepatit-e"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/antifibroticnite-efekti-na-zelenia-cai</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/antifibroticnite-efekti-na-zelenia-cai"/>
  <lastmod>2018-06-24T17:24:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/svrzanoto-s-paracetamol-uvrezdane-na-cernia-drob-moze-da-bde-predotvrateno-s-pomosta-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/svrzanoto-s-paracetamol-uvrezdane-na-cernia-drob-moze-da-bde-predotvrateno-s-pomosta-na"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kolko-vreme-trae-zasitata-na-vaksinata-sresu-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kolko-vreme-trae-zasitata-na-vaksinata-sresu-hepatit-v"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izcistva-li-se-hbsag-sled-lecenie-na-infekciata-s-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izcistva-li-se-hbsag-sled-lecenie-na-infekciata-s-hepatit-v"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-da-upravlavam-zabolavaneto-pri-hbeag-pozitivna-bremenna-zena</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-da-upravlavam-zabolavaneto-pri-hbeag-pozitivna-bremenna-zena"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledovateli-ot-universiteta-erazmus-opovestavat-novi-danni-za-virusa-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledovateli-ot-universiteta-erazmus-opovestavat-novi-danni-za-virusa-na-hepatit-v"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vitamin-d-podpomaga-lecenieto-na-hronicen-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vitamin-d-podpomaga-lecenieto-na-hronicen-hepatit-c"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/niski-trombociti-anti-nsv-antitela-predricat-nsv-viremia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/niski-trombociti-anti-nsv-antitela-predricat-nsv-viremia"/>
  <lastmod>2018-05-12T15:42:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vodesite-novini-prez-2009-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vodesite-novini-prez-2009-godina"/>
  <lastmod>2018-05-12T15:43:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kompaniata-intermune-pridvizva-napred-programata-za-szdavane-na-proteazen-inhibitor-rg7227-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kompaniata-intermune-pridvizva-napred-programata-za-szdavane-na-proteazen-inhibitor-rg7227-za"/>
  <lastmod>2018-05-12T15:43:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prirodno-sedinenie-blokira-infekciata-s-hepatit-s-otkritieto-moze-da-dovede-do-novo-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prirodno-sedinenie-blokira-infekciata-s-hepatit-s-otkritieto-moze-da-dovede-do-novo-lecenie"/>
  <lastmod>2018-05-12T15:43:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/faktori-predskazvasi-kakv-se-e-otgovora-na-pegiliran-interferon-pri-hbeag-pozitivni-pacienti-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/faktori-predskazvasi-kakv-se-e-otgovora-na-pegiliran-interferon-pri-hbeag-pozitivni-pacienti-s"/>
  <lastmod>2018-05-12T15:43:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kafeto-namalava-cernodrobnata-cikatrizacia-pri-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kafeto-namalava-cernodrobnata-cikatrizacia-pri-hepatit-s"/>
  <lastmod>2018-05-12T15:43:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/idenix-pharmaceuticals-iztkva-napredka-si-v-tri-nsv-programi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/idenix-pharmaceuticals-iztkva-napredka-si-v-tri-nsv-programi"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dlgosrocniat-priem-na-entecavir-baraclude-vodi-do-traina-virusna-supresia-i-malka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dlgosrocniat-priem-na-entecavir-baraclude-vodi-do-traina-virusna-supresia-i-malka"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-viread-vodi-do-dlgosrocen-otgovor-pri-pacienti-s-hronicen-hepatit-v-i-predsestvaso</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-viread-vodi-do-dlgosrocen-otgovor-pri-pacienti-s-hronicen-hepatit-v-i-predsestvaso"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/na-konferencia-na-investitori-vertex-intermune-i-idenix-predstavat-posledni-danni-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/na-konferencia-na-investitori-vertex-intermune-i-idenix-predstavat-posledni-danni-za"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lecenie-na-nsv-4-sedmicno-vstpitelno-lecenie-s-nitazoxanide-predi-peginterferon-plus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lecenie-na-nsv-4-sedmicno-vstpitelno-lecenie-s-nitazoxanide-predi-peginterferon-plus"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/progresirane-na-prvonacalno-lekata-cernodrobna-fibroza-pri-hora-s-hronicen-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/progresirane-na-prvonacalno-lekata-cernodrobna-fibroza-pri-hora-s-hronicen-hepatit-s"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvane-na-hbsag-polozitelni-bremenni-zeni-i-tehnite-deca-s-ogled-merkite-za-prevencia-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvane-na-hbsag-polozitelni-bremenni-zeni-i-tehnite-deca-s-ogled-merkite-za-prevencia-na"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzrastta-po-vreme-na-hbeag-serokonversia-predskazva-prognozata-za-hronicnia-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzrastta-po-vreme-na-hbeag-serokonversia-predskazva-prognozata-za-hronicnia-hepatit-v"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/entekavir-baraclude-podobrava-cernodrobnata-funkcia-pri-pacienti-s-hronicen-hepatit-v-i</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/entekavir-baraclude-podobrava-cernodrobnata-funkcia-pri-pacienti-s-hronicen-hepatit-v-i"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uceni-proucvat-vrzkata-mezdu-hepatit-c-i-diabeta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uceni-proucvat-vrzkata-mezdu-hepatit-c-i-diabeta"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vazno-proucvane-se-opitva-da-otkrie-vaksina-za-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vazno-proucvane-se-opitva-da-otkrie-vaksina-za-hepatit-c"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/siroko-razprostranen-test-za-otkrivane-na-cernodrobni-problemi-pri-decata-cesto-se</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/siroko-razprostranen-test-za-otkrivane-na-cernodrobni-problemi-pri-decata-cesto-se"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/optimizmt-podsilva-imunnata-sistema</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/optimizmt-podsilva-imunnata-sistema"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/visokofruktozniat-carevicen-sirop-se-svrzva-s-uvrezdane-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/visokofruktozniat-carevicen-sirop-se-svrzva-s-uvrezdane-na-cernia-drob"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uspesna-kratkosrocna-monoterapia-s-pegiliran-interferon-na-hronicen-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uspesna-kratkosrocna-monoterapia-s-pegiliran-interferon-na-hronicen-hepatit-c"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/interferon-baziranata-terapia-e-po-malko-efektivna-za-pacientite-s-hepatit-c-s-naprednala</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/interferon-baziranata-terapia-e-po-malko-efektivna-za-pacientite-s-hepatit-c-s-naprednala"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novi-dokazatelstva-za-belia-trn-magareski-bodil</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novi-dokazatelstva-za-belia-trn-magareski-bodil"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/virust-na-hepatit-c-moze-da-ocelee-v-sprincovki-do-2-meseca-pri-blagopriatni-uslovia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/virust-na-hepatit-c-moze-da-ocelee-v-sprincovki-do-2-meseca-pri-blagopriatni-uslovia"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nivata-na-hbv-dna-i-hbsag-predskazvat-veroatnostta-ot-traen-otgovor-pri-lecenieto-na-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nivata-na-hbv-dna-i-hbsag-predskazvat-veroatnostta-ot-traen-otgovor-pri-lecenieto-na-hepatit-b"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prediktori-na-brz-i-ranen-virusologicen-otgovor-na-lecenie-s-pegiliran-interferon-plus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prediktori-na-brz-i-ranen-virusologicen-otgovor-na-lecenie-s-pegiliran-interferon-plus"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uslozneniata-ot-hronicen-hepatit-s-narastvat-osobeno-pri-horata-nad-60-godisna-vzrast</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uslozneniata-ot-hronicen-hepatit-s-narastvat-osobeno-pri-horata-nad-60-godisna-vzrast"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/po-vzrastnite-pacienti-imat-povece-stranicni-efekti-ot-terapia-na-baza-interferon-no-mnozina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/po-vzrastnite-pacienti-imat-povece-stranicni-efekti-ot-terapia-na-baza-interferon-no-mnozina"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izglezda-ce-dobavkite-za-cernia-drob-ne-osiguravat-zasita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izglezda-ce-dobavkite-za-cernia-drob-ne-osiguravat-zasita"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dali-ediniat-vid-pegiliran-interferon-e-po-efektiven-pri-lecenie-na-hronicen-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dali-ediniat-vid-pegiliran-interferon-e-po-efektiven-pri-lecenie-na-hronicen-hepatit-c"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pegasis-ili-pegintron-koe-odobreno-ot-fda-lekarstvo-e-po-dobro-za-lecenie-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pegasis-ili-pegintron-koe-odobreno-ot-fda-lekarstvo-e-po-dobro-za-lecenie-na-hepatit-c"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/cerniat-sokolad-veroatno-lekuva-cernodrobni-narusenia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/cerniat-sokolad-veroatno-lekuva-cernodrobni-narusenia"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tradicionnata-kitaiska-medicina-moze-da-vrsi-po-dobra-rabota-otkolkoto-interferon-ili</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tradicionnata-kitaiska-medicina-moze-da-vrsi-po-dobra-rabota-otkolkoto-interferon-ili"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/strogo-individualiziranoto-lecenie-s-pegiliran-interferon-plus-ribavirin-e-vzmozno-vz-osnova</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/strogo-individualiziranoto-lecenie-s-pegiliran-interferon-plus-ribavirin-e-vzmozno-vz-osnova"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/v-laboratorno-proucvane-ekstraktite-na-silibinina-v-belia-trn-vzprepatstvat-nsv-polimerazata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/v-laboratorno-proucvane-ekstraktite-na-silibinina-v-belia-trn-vzprepatstvat-nsv-polimerazata"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/skromni-rezultati-s-nitazoxanide-pri-neotgovorili-pacienti-s-hcv-genotip-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/skromni-rezultati-s-nitazoxanide-pri-neotgovorili-pacienti-s-hcv-genotip-1"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spored-izsledvane-107-59-ot-vsicki-pacienti-s-terapevticen-rezim-na-baza-telaprevir-sa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spored-izsledvane-107-59-ot-vsicki-pacienti-s-terapevticen-rezim-na-baza-telaprevir-sa"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ddw-vitamin-podpomaga-otgovora-na-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ddw-vitamin-podpomaga-otgovora-na-lecenieto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nitazoksanid-uvelicava-otgovora-na-pegilirania-interferon-plus-ribavirin-pri-terapevticno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nitazoksanid-uvelicava-otgovora-na-pegilirania-interferon-plus-ribavirin-pri-terapevticno"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/visok-risk-ot-hepatocelularen-karcinom-pri-pacienti-s-hepatit-c-i-povisena-insulinova</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/visok-risk-ot-hepatocelularen-karcinom-pri-pacienti-s-hepatit-c-i-povisena-insulinova"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spadt-na-hbeag-po-vreme-na-lecenie-predskazva-trainia-otgovor-na-pegiliran-interferon-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spadt-na-hbeag-po-vreme-na-lecenie-predskazva-trainia-otgovor-na-pegiliran-interferon-za"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/svetovniat-hepatiten-alians-privetstva-resenieto-na-svetovnata-zdravna-asamblea-na-szo-otnosno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/svetovniat-hepatiten-alians-privetstva-resenieto-na-svetovnata-zdravna-asamblea-na-szo-otnosno"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/po-prodlzitelnoto-lecenie-s-pegiliran-interferon-deistva-po-dobre-pri-hepatit-v-genotip-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/po-prodlzitelnoto-lecenie-s-pegiliran-interferon-deistva-po-dobre-pri-hepatit-v-genotip-d"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/75-ot-terapevticno-naivnite-pacienti-s-hronicen-hepatit-s-postigat-svr-virusno-izlekuvane-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/75-ot-terapevticno-naivnite-pacienti-s-hronicen-hepatit-s-postigat-svr-virusno-izlekuvane-s"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/interferont-s-kontrolirano-osvobozdavane-locteron-prilagan-na-vseki-2-sedmici-deistva-sso-taka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/interferont-s-kontrolirano-osvobozdavane-locteron-prilagan-na-vseki-2-sedmici-deistva-sso-taka"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spontannoto-postigane-na-neotkrivaema-nvv-dnk-se-sresa-radko-osobeno-bez-izcistvane-na-hbeag</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spontannoto-postigane-na-neotkrivaema-nvv-dnk-se-sresa-radko-osobeno-bez-izcistvane-na-hbeag"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vitamin-d-uvelicava-trainia-otgovor-na-baziranata-na-interferon-terapia-za-hepatit-s-i-moze-da</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vitamin-d-uvelicava-trainia-otgovor-na-baziranata-na-interferon-terapia-za-hepatit-s-i-moze-da"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/proucvane-ustanovava-ce-vzstanovavaneto-ot-hepatit-s-ne-osigurava-zasita-ot-bdesa-infekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/proucvane-ustanovava-ce-vzstanovavaneto-ot-hepatit-s-ne-osigurava-zasita-ot-bdesa-infekcia"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/svrzanata-s-tenofovir-bbrecna-toksicnost-dlzasa-se-na-visoka-lekarstvena-koncentracia-ne</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/svrzanata-s-tenofovir-bbrecna-toksicnost-dlzasa-se-na-visoka-lekarstvena-koncentracia-ne"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/5-pricini-da-se-trevozim-za-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/5-pricini-da-se-trevozim-za-telaprevir"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izlozen-li-si-na-po-visok-risk-ot-diabet-tip-2-ako-imas-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izlozen-li-si-na-po-visok-risk-ot-diabet-tip-2-ako-imas-hepatit-s"/>
  <lastmod>2018-05-12T15:43:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/alkalnata-fosfataza-alp-predskazva-recidiv-pri-pacienti-s-hronicen-hepatit-s-i-s-otgovor-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/alkalnata-fosfataza-alp-predskazva-recidiv-pri-pacienti-s-hronicen-hepatit-s-i-s-otgovor-v"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kolko-dlgo-trabva-da-bdat-lekuvani-pacientite-s-hronicen-hepatit-v-za-da-zadrzat-hbeag</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kolko-dlgo-trabva-da-bdat-lekuvani-pacientite-s-hronicen-hepatit-v-za-da-zadrzat-hbeag"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vlianie-na-cernodrobnata-steatoza-vrhu-estestvenata-istoria-na-hronicnata-nsv-infekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vlianie-na-cernodrobnata-steatoza-vrhu-estestvenata-istoria-na-hronicnata-nsv-infekcia"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konsumiraneto-na-kofein-se-svrzva-s-namalena-cernodrobna-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konsumiraneto-na-kofein-se-svrzva-s-namalena-cernodrobna-fibroza"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/borovinkite-podobravat-cernodrobnata-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/borovinkite-podobravat-cernodrobnata-fibroza"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uceni-proizvezdat-v-laboratoria-ceren-drob-ot-stvolovi-kletki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uceni-proizvezdat-v-laboratoria-ceren-drob-ot-stvolovi-kletki"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzaimodeistvie-mezdu-puseneto-i-infekciata-s-virusa-na-hepatit-v-i-hepatit-s-s-riska-ot-rak-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzaimodeistvie-mezdu-puseneto-i-infekciata-s-virusa-na-hepatit-v-i-hepatit-s-s-riska-ot-rak-na"/>
  <lastmod>2018-05-12T15:44:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/proteazniat-hcv-inhibitor-boceprevir-uvelicava-trainia-otgovor-na-interferon-bazirana-terapia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/proteazniat-hcv-inhibitor-boceprevir-uvelicava-trainia-otgovor-na-interferon-bazirana-terapia"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vlianie-na-ekstrakta-ot-bal-trn-vrhu-ziznenia-cikl-na-virusa-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vlianie-na-ekstrakta-ot-bal-trn-vrhu-ziznenia-cikl-na-virusa-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prodlzitelnoto-lecenie-na-hcv-genotip-1-e-polezno-pri-licata-s-baven-otgovor</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prodlzitelnoto-lecenie-na-hcv-genotip-1-e-polezno-pri-licata-s-baven-otgovor"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepatit-c-i-insulinova-rezistentnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepatit-c-i-insulinova-rezistentnost"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstvoto-za-hepatit-na-merck-deistva-nabludavana-e-anemia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstvoto-za-hepatit-na-merck-deistva-nabludavana-e-anemia"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otgovor-na-8-ta-sedmica-prognozira-tocno-trainia-otgovor-na-pegiliran-interferon-plus</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otgovor-na-8-ta-sedmica-prognozira-tocno-trainia-otgovor-na-pegiliran-interferon-plus"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/povtorno-lecenie-s-pegiliran-interferon-na-pacienti-s-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/povtorno-lecenie-s-pegiliran-interferon-na-pacienti-s-hepatit-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/meta-analiz-ustanovava-ce-tenofovir-i-entecavir-sa-nai-efektivnite-antivirusni-lekarstva-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/meta-analiz-ustanovava-ce-tenofovir-i-entecavir-sa-nai-efektivnite-antivirusni-lekarstva-za"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstvo-za-hepatit-b-se-bori-s-cernodrobnata-fibroza-i-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstvo-za-hepatit-b-se-bori-s-cernodrobnata-fibroza-i-ciroza"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spad-na-hbv-dnk-na-24-ta-sedmica-prognozira-traen-otgovor-na-pegilirania-interferon-pri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spad-na-hbv-dnk-na-24-ta-sedmica-prognozira-traen-otgovor-na-pegilirania-interferon-pri"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/problemi-ss-zbite-otlagat-zapocvaneto-na-lecenie-s-interferon-na-zarazeni-s-nsv-pacienti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/problemi-ss-zbite-otlagat-zapocvaneto-na-lecenie-s-interferon-na-zarazeni-s-nsv-pacienti"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ima-li-podobrenie-v-zdravoslovnoto-sstoanie-na-cernia-drob-bez-svr</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ima-li-podobrenie-v-zdravoslovnoto-sstoanie-na-cernia-drob-bez-svr"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/brziat-virusologicen-otgovor-na-4-ta-sedmica-prognozira-traen-otgovor-na-interferon-bazirano</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/brziat-virusologicen-otgovor-na-4-ta-sedmica-prognozira-traen-otgovor-na-interferon-bazirano"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vazni-rezultati-boceprevir-telaprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vazni-rezultati-boceprevir-telaprevir"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pegiliraniat-interferon-plus-ribavirin-ima-visok-procent-na-traen-otgovor-pri-decata-s-hepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pegiliraniat-interferon-plus-ribavirin-ima-visok-procent-na-traen-otgovor-pri-decata-s-hepatit"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tatuirovkite-uvelicavat-riska-ot-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tatuirovkite-uvelicavat-riska-ot-hepatit-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vrzkata-mezdu-hepatit-s-i-avtoimunnite-zabolavania</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vrzkata-mezdu-hepatit-s-i-avtoimunnite-zabolavania"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstva-izpolzvani-za-lecenie-na-diabet-i-zatlstavane-mogat-da-pomognat-v-lecenieto-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstva-izpolzvani-za-lecenie-na-diabet-i-zatlstavane-mogat-da-pomognat-v-lecenieto-na"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telaprevir-ili-boceprevir-niva-na-postignat-svr-spored-genotipa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telaprevir-ili-boceprevir-niva-na-postignat-svr-spored-genotipa"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nai-vaznite-rezultati-ot-proucvaneto-realize</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nai-vaznite-rezultati-ot-proucvaneto-realize"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/virust-na-hepatit-c-pricinava-vzpalenie-na-mozka-koeto-vodi-do-uvrezdane-na-nevronite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/virust-na-hepatit-c-pricinava-vzpalenie-na-mozka-koeto-vodi-do-uvrezdane-na-nevronite"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pegiliraniat-interferon-ima-nisk-procent-na-traen-otgovor-pri-hbeag-negativni-pacienti-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pegiliraniat-interferon-ima-nisk-procent-na-traen-otgovor-pri-hbeag-negativni-pacienti-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/deficit-na-vitamin-d-pri-hronicno-cernodrobno-zabolavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/deficit-na-vitamin-d-pri-hronicno-cernodrobno-zabolavane"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dve-vazni-otkritia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dve-vazni-otkritia"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/heteroseksualniat-seks-ne-e-osnoven-riskov-faktor-za-predavane-na-virusa-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/heteroseksualniat-seks-ne-e-osnoven-riskov-faktor-za-predavane-na-virusa-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dlgosrocnata-upotreba-na-entecavir-vodi-do-regresia-na-cernodrobnata-fibroza-pri-pacienti-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dlgosrocnata-upotreba-na-entecavir-vodi-do-regresia-na-cernodrobnata-fibroza-pri-pacienti-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-viread-poddrza-supresia-na-hbv-bez-rezistentnost-v-prodlzenie-na-4-godini</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-viread-poddrza-supresia-na-hbv-bez-rezistentnost-v-prodlzenie-na-4-godini"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dlgosrocnite-rezultati-sa-po-dobri-s-traen-virusologicen-otgovor-svr</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dlgosrocnite-rezultati-sa-po-dobri-s-traen-virusologicen-otgovor-svr"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/direktno-deistvasite-lekarstva-danoprevir-danoprevir-plus-rg7128-potiskat-supresirat-hcv-bez</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/direktno-deistvasite-lekarstva-danoprevir-danoprevir-plus-rg7128-potiskat-supresirat-hcv-bez"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/okoncatelni-rezultati-ot-klinicnoto-izpitvane-na-boceprevir-boceprevir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/okoncatelni-rezultati-ot-klinicnoto-izpitvane-na-boceprevir-boceprevir"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/riskovi-faktori-za-infekcia-po-vreme-na-lecenieto-na-hronicen-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/riskovi-faktori-za-infekcia-po-vreme-na-lecenieto-na-hronicen-hepatit-s"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telaprevir-telaprevir-uvelicava-procentite-na-traen-virusologicen-otgovor-i-skrasava</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telaprevir-telaprevir-uvelicava-procentite-na-traen-virusologicen-otgovor-i-skrasava"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/serologicnoto-razprostranenie-na-hepatit-c-pri-diabet-tip-2-dokazatelstva-za-polozitelna-vrzka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/serologicnoto-razprostranenie-na-hepatit-c-pri-diabet-tip-2-dokazatelstva-za-polozitelna-vrzka"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/efektivnostta-i-bezopasnostta-na-tenofovir-v-klinicna-praktika-v-realnia-zivot</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/efektivnostta-i-bezopasnostta-na-tenofovir-v-klinicna-praktika-v-realnia-zivot"/>
  <lastmod>2018-05-12T15:44:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zehtint-pazi-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zehtint-pazi-cernia-drob"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/cervenoto-meso-uvelicava-riska-ot-uvrezdane-na-cernia-drob-pri-lica-s-hronicni-cernodrobni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/cervenoto-meso-uvelicava-riska-ot-uvrezdane-na-cernia-drob-pri-lica-s-hronicni-cernodrobni"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telbivudin-i-cezarovo-secenie-po-izbor-pomagat-da-se-predotvrati-predavaneto-na-hepatit-v-ot</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telbivudin-i-cezarovo-secenie-po-izbor-pomagat-da-se-predotvrati-predavaneto-na-hepatit-v-ot"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/antivirusna-terapia-za-pacienti-s-hronicen-hepatit-v-i-dekompensirana-ciroza-na-cernia-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/antivirusna-terapia-za-pacienti-s-hronicen-hepatit-v-i-dekompensirana-ciroza-na-cernia-drob"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/potencialno-novi-metodi-za-lecenie-na-hepatit-b-i-tuberkuloza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/potencialno-novi-metodi-za-lecenie-na-hepatit-b-i-tuberkuloza"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/direktno-deistvasi-lekarstveni-kombinacii-potiskat-nsv-bez-interferon-no-rezistentnostta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/direktno-deistvasi-lekarstveni-kombinacii-potiskat-nsv-bez-interferon-no-rezistentnostta"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/10-te-top-novini-na-2010-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/10-te-top-novini-na-2010-godina"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konsumaciata-na-povece-kafe-e-svrzana-s-podobren-otgovor-na-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konsumaciata-na-povece-kafe-e-svrzana-s-podobren-otgovor-na-lecenieto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/predvaritelnoto-lecenie-s-ribavirin-podobrava-otgovora-pri-interferon-bazirano-lecenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/predvaritelnoto-lecenie-s-ribavirin-podobrava-otgovora-pri-interferon-bazirano-lecenie-na"/>
  <lastmod>2018-05-12T15:44:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ustroistvo-na-izkustven-ceren-drob-podobrava-prezivaemostta-pri-pacienti-s-hepatit-v-i-s-i</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ustroistvo-na-izkustven-ceren-drob-podobrava-prezivaemostta-pri-pacienti-s-hepatit-v-i-s-i"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/menopauzata-i-zatlstavaneto-sa-svrzani-s-recidiv-na-hcv-sled-interferon-bazirana-terapia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/menopauzata-i-zatlstavaneto-sa-svrzani-s-recidiv-na-hcv-sled-interferon-bazirana-terapia"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sled-3-godini-lipsva-rezistentnost-km-tenofovir-sred-pacienti-s-hronicen-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sled-3-godini-lipsva-rezistentnost-km-tenofovir-sred-pacienti-s-hronicen-hepatit-v"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/anemiata-po-vreme-na-lecenie-na-hepatit-s-predvesava-traen-otgovor-na-pegiliran</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/anemiata-po-vreme-na-lecenie-na-hepatit-s-predvesava-traen-otgovor-na-pegiliran"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prvite-pacienti-s-cernodrobna-transplantacia-polucavat-eksperimentalno-lekarstvo-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prvite-pacienti-s-cernodrobna-transplantacia-polucavat-eksperimentalno-lekarstvo-za"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/edna-cetvrt-ot-pacientite-izcistvat-hepatit-delta-s-pegiliran-interferon</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/edna-cetvrt-ot-pacientite-izcistvat-hepatit-delta-s-pegiliran-interferon"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacientite-s-hepatit-c-moze-da-sa-izlozeni-na-povisen-risk-ot-insult</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacientite-s-hepatit-c-moze-da-sa-izlozeni-na-povisen-risk-ot-insult"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novinite-nakratko-fevruari-2011</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novinite-nakratko-fevruari-2011"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lecenie-na-rekurenten-recidiviral-hepatit-c-sled-cernodrobna-transplantacia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lecenie-na-rekurenten-recidiviral-hepatit-c-sled-cernodrobna-transplantacia"/>
  <lastmod>2018-05-12T15:44:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/entekavir-entecavir-e-odobren-v-evropa-za-pacienti-s-hepatit-v-i-dekompensirani-cernodrobni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/entekavir-entecavir-e-odobren-v-evropa-za-pacienti-s-hepatit-v-i-dekompensirani-cernodrobni"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hcv-proteazniat-inhibitor-boceprevir-podobrava-otgovora-pri-terapevticno-naivni-nelekuvani-i</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hcv-proteazniat-inhibitor-boceprevir-podobrava-otgovora-pri-terapevticno-naivni-nelekuvani-i"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ocertavat-se-novi-terapevticni-vzmoznosti-za-pacientite-s-koinfekcia-s-hiv-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ocertavat-se-novi-terapevticni-vzmoznosti-za-pacientite-s-koinfekcia-s-hiv-i-hepatit-s"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/fda-odobrava-victrelis-i-incivek</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/fda-odobrava-victrelis-i-incivek"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/maikite-s-hepatit-b-mogat-da-krmat-bez-opasnost-da-zarazat-bebeto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/maikite-s-hepatit-b-mogat-da-krmat-bez-opasnost-da-zarazat-bebeto"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hbv-antivirusni-preparati-virusen-probiv-i-lekarstvena-rezistentnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hbv-antivirusni-preparati-virusen-probiv-i-lekarstvena-rezistentnost"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/genotip-na-hbv-prognozira-hbeag-serokonversia-pri-lecenie-s-tenofovir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/genotip-na-hbv-prognozira-hbeag-serokonversia-pri-lecenie-s-tenofovir"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bustiran-podsilen-danoprevir-podobrava-otgovora-pri-predisni-nulevi-responderi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bustiran-podsilen-danoprevir-podobrava-otgovora-pri-predisni-nulevi-responderi"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/statin-podobrava-otgovora-na-pegiliran-interferon-plus-ribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/statin-podobrava-otgovora-na-pegiliran-interferon-plus-ribavirin"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/po-prodlzitelno-lecenie-s-interferon-uvelicava-procenta-na-izlekuvane-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/po-prodlzitelno-lecenie-s-interferon-uvelicava-procenta-na-izlekuvane-na-hepatit-c"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dlgosrocna-efikasnost-na-entekavir-pri-hora-s-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dlgosrocna-efikasnost-na-entekavir-pri-hora-s-hepatit-b"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kombinaciata-bms-790052bms-650032-lekuva-hepatit-s-bez-interferon</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kombinaciata-bms-790052bms-650032-lekuva-hepatit-s-bez-interferon"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kafeto-podobrava-otgovora-na-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kafeto-podobrava-otgovora-na-lecenieto-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kofeint-i-zabolavaniata-na-cernia-drob-pri-horata-s-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kofeint-i-zabolavaniata-na-cernia-drob-pri-horata-s-hepatit-c"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pharmasset-98-do-100-izlekuvani</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pharmasset-98-do-100-izlekuvani"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/virust-na-hepatit-s-moze-da-uvelici-riska-ot-mozcni-uvrezdania-i-smrt-pri-hiv-pozitivnite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/virust-na-hepatit-s-moze-da-uvelici-riska-ot-mozcni-uvrezdania-i-smrt-pri-hiv-pozitivnite"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nova-tehnologia-na-vaksina-zasitava-miski-ot-virusa-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nova-tehnologia-na-vaksina-zasitava-miski-ot-virusa-na-hepatit-c"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nakoi-lica-s-hepatit-v-moze-da-imat-nuzda-ot-skrining-za-rak-na-cernia-drob-po-rano-i-po-cesto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nakoi-lica-s-hepatit-v-moze-da-imat-nuzda-ot-skrining-za-rak-na-cernia-drob-po-rano-i-po-cesto"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aasld-prodlzitelniat-priem-na-tenofovir-za-hronicen-hepatit-v-namalava-vzpalenieto-na-cernia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aasld-prodlzitelniat-priem-na-tenofovir-za-hronicen-hepatit-v-namalava-vzpalenieto-na-cernia"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/2011-pregled-na-godinata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/2011-pregled-na-godinata"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/predvaritelni-preporki-za-prilagane-na-proteaznite-inhibitori-za-lecenie-na-hepatit-s-pri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/predvaritelni-preporki-za-prilagane-na-proteaznite-inhibitori-za-lecenie-na-hepatit-s-pri"/>
  <lastmod>2018-05-12T15:44:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sobsenie-za-lekarstveni-vzaimodeistvia-mezdu-victrelis-i-proteaznite-inhibitori-za-lecenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sobsenie-za-lekarstveni-vzaimodeistvia-mezdu-victrelis-i-proteaznite-inhibitori-za-lecenie-na"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sobsenie-za-lekarstveni-vzaimodeistvia-mezdu-proteaznite-inhibitori-i-statinite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sobsenie-za-lekarstveni-vzaimodeistvia-mezdu-proteaznite-inhibitori-i-statinite"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vazni-promeni-v-listovkite-na-statinite-zasagasi-bezopasnata-im-upotreba</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vazni-promeni-v-listovkite-na-statinite-zasagasi-bezopasnata-im-upotreba"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kanadski-izsledovateli-postigat-napredk-v-trsene-na-vaksina-sresu-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kanadski-izsledovateli-postigat-napredk-v-trsene-na-vaksina-sresu-hepatit-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aasld-estestvena-istoria-na-infekciata-s-hepatit-b-i-rolata-na-hbv-genotipa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aasld-estestvena-istoria-na-infekciata-s-hepatit-b-i-rolata-na-hbv-genotipa"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/upravlenie-na-stranicnite-efekti-na-novite-proteazni-inhibitori-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/upravlenie-na-stranicnite-efekti-na-novite-proteazni-inhibitori-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kafeto-moze-da-namali-fibrozata-pri-hora-s-mastno-cernodrobno-zabolavane-cernodrobna-steatoza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kafeto-moze-da-namali-fibrozata-pri-hora-s-mastno-cernodrobno-zabolavane-cernodrobna-steatoza"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/popularni-no-opasni-3-vitamina-koito-mogat-da-vi-navredat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/popularni-no-opasni-3-vitamina-koito-mogat-da-vi-navredat"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telaprevir-i-boceprevir-podobravat-procenta-na-traen-otgovor-pri-pacienti-s-hivnsv-koinfekcia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telaprevir-i-boceprevir-podobravat-procenta-na-traen-otgovor-pri-pacienti-s-hivnsv-koinfekcia"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uceni-otkriha-antitela-koito-neutralizirat-mnozestvo-samove-na-virusa-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uceni-otkriha-antitela-koito-neutralizirat-mnozestvo-samove-na-virusa-na-hepatit-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstva-v-proces-na-razrabotka-aktualizacia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstva-v-proces-na-razrabotka-aktualizacia"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/podtip-1b-na-virusa-na-hepatit-s-i-nositelstvoto-na-gena-il28b-se-svrzvat-s-po-dobr-otgovor-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/podtip-1b-na-virusa-na-hepatit-s-i-nositelstvoto-na-gena-il28b-se-svrzvat-s-po-dobr-otgovor-na"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aktualiziranite-amerikanski-preporki-davat-vazni-sveti-otnosno-lecenieto-na-hiv-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aktualiziranite-amerikanski-preporki-davat-vazni-sveti-otnosno-lecenieto-na-hiv-i-hepatit-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spontannoto-ocistvane-ili-izlekuvaneto-ot-ostr-hepatit-s-ne-predpazva-ot-povtorna-infekcia-hiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spontannoto-ocistvane-ili-izlekuvaneto-ot-ostr-hepatit-s-ne-predpazva-ot-povtorna-infekcia-hiv"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/infektiraneto-s-hepatit-s-e-dva-pti-po-veroatno-pri-hiv-pozitivnite-mze-koito-pravat-seks-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/infektiraneto-s-hepatit-s-e-dva-pti-po-veroatno-pri-hiv-pozitivnite-mze-koito-pravat-seks-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rezultati-ot-edno-amerikansko-proucvane-vrhu-prisazdaneto-na-ceren-drob-pri-pacienti-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rezultati-ot-edno-amerikansko-proucvane-vrhu-prisazdaneto-na-ceren-drob-pri-pacienti-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/koinfekciata-s-hepatit-s-uvelicava-s-50-riska-ot-nastpvane-na-smrt-pri-pacientite-ss-spin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/koinfekciata-s-hepatit-s-uvelicava-s-50-riska-ot-nastpvane-na-smrt-pri-pacientite-ss-spin"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dva-pti-po-visok-risk-ot-nastpvane-na-smrt-poradi-cernodrobno-uvrezdane-pri-hiv-pozitivnite-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dva-pti-po-visok-risk-ot-nastpvane-na-smrt-poradi-cernodrobno-uvrezdane-pri-hiv-pozitivnite-s"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izlekuvaneto-ot-hepatit-s-doprinasa-za-obsoto-zdrave-i-prezivaemostta-na-hiv-pozitivnite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izlekuvaneto-ot-hepatit-s-doprinasa-za-obsoto-zdrave-i-prezivaemostta-na-hiv-pozitivnite"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-telaprevir-i-boceprevir-sa-efektivni-no</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-telaprevir-i-boceprevir-sa-efektivni-no"/>
  <lastmod>2018-05-12T15:44:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-simeprevir-tmc435-podobrava-procentite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-simeprevir-tmc435-podobrava-procentite"/>
  <lastmod>2018-05-12T15:45:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-interferon-lambda-e-tolkova-efektiven</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-interferon-lambda-e-tolkova-efektiven"/>
  <lastmod>2018-05-12T15:45:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-nalicieto-samo-na-div-tip-na-virusa-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-nalicieto-samo-na-div-tip-na-virusa-na"/>
  <lastmod>2018-05-12T15:45:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-gs-7977-daclatasvir-i-asunaprevir-se</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-gs-7977-daclatasvir-i-asunaprevir-se"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-boceprevir-boceprevir-polezna-opcia-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-boceprevir-boceprevir-polezna-opcia-za"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-kombinacii-za-nsv-bez-interferon-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-kombinacii-za-nsv-bez-interferon-na"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/koreiska-mumia-razkriva-geneticni-sledi-na-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/koreiska-mumia-razkriva-geneticni-sledi-na-hepatit-v"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-namalavaneto-na-dozata-ribavirin-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-namalavaneto-na-dozata-ribavirin-e"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-telaprevir-e-100-efektiven-za-il28b-cc</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-evropeiska-asociacia-za-izucavane-na-cernia-drob-telaprevir-e-100-efektiven-za-il28b-cc"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nama-danni-za-vzaimodeistvie-mezdu-abacavir-i-ribavirin</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nama-danni-za-vzaimodeistvie-mezdu-abacavir-i-ribavirin"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hronicniat-hepatit-s-uvelicava-povece-ot-dva-pti-riska-ot-bbrecna-bolest-pri-hiv-pozitivnite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hronicniat-hepatit-s-uvelicava-povece-ot-dva-pti-riska-ot-bbrecna-bolest-pri-hiv-pozitivnite"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/genotipt-na-hbv-vliae-vrhu-progresiraneto-na-hepatit-v-i-izhoda-ot-nego</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/genotipt-na-hbv-vliae-vrhu-progresiraneto-na-hepatit-v-i-izhoda-ot-nego"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vaksina-sresu-hepatit-v-osigurava-zasita-v-prodlzenie-na-25-godini-proucvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vaksina-sresu-hepatit-v-osigurava-zasita-v-prodlzenie-na-25-godini-proucvane"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lecenieto-na-hcv-i-mozkt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lecenieto-na-hcv-i-mozkt"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lecenieto-na-hepatit-s-makar-i-da-ne-dovede-do-izlekuvane-moze-da-podobri-fibrozata-na-cernia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lecenieto-na-hepatit-s-makar-i-da-ne-dovede-do-izlekuvane-moze-da-podobri-fibrozata-na-cernia"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledovateli-otglezdat-cernodrobna-tkan-ot-pluripotentni-stvolovi-kletki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledovateli-otglezdat-cernodrobna-tkan-ot-pluripotentni-stvolovi-kletki"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-publikuva-aktualizirani-nasoki-za-dobra-klinicna-praktika-za-hronicen-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-publikuva-aktualizirani-nasoki-za-dobra-klinicna-praktika-za-hronicen-hepatit-b"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekuvane-na-umorata-sptstvasa-terapiata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekuvane-na-umorata-sptstvasa-terapiata"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izlekuvane-naistina-li</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izlekuvane-naistina-li"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/beliat-trn-ne-namalava-vzpalenieto-na-cernia-drob-pri-neotgovorili-pacienti-s-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/beliat-trn-ne-namalava-vzpalenieto-na-cernia-drob-pri-neotgovorili-pacienti-s-hepatit-s"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/monoklonalni-antitela-moze-da-pomognat-za-predpazvane-ot-i-izcistvane-na-virusa-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/monoklonalni-antitela-moze-da-pomognat-za-predpazvane-ot-i-izcistvane-na-virusa-na-hepatit-s"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lipsata-na-sn-moze-da-komprometira-otgovora-na-vaksinata-sresu-hepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lipsata-na-sn-moze-da-komprometira-otgovora-na-vaksinata-sresu-hepatit-v"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ranni-promeni-v-opredeleni-biomarkeri-prognozirat-koi-pacienti-s-hepatit-s-razvivat-tezko</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ranni-promeni-v-opredeleni-biomarkeri-prognozirat-koi-pacienti-s-hepatit-s-razvivat-tezko"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aktualizacia-na-lekarstvenata-listovka-na-tenofovir-za-hepatit-v-dobava-informacia-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aktualizacia-na-lekarstvenata-listovka-na-tenofovir-za-hepatit-v-dobava-informacia-za"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vaksinata-za-hepatit-b-e-s-dlgotraina-efektivnost-no-nakoi-hora-gubat-zasita-sled-15-godini</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vaksinata-za-hepatit-b-e-s-dlgotraina-efektivnost-no-nakoi-hora-gubat-zasita-sled-15-godini"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nedostigt-na-vitamin-d-se-svrzva-s-po-slab-otgovor-na-lecenieto-za-hepatit-s-pri-pacientite-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nedostigt-na-vitamin-d-se-svrzva-s-po-slab-otgovor-na-lecenieto-za-hepatit-s-pri-pacientite-s"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hiv-infekciata-komprometira-hcv-specificnia-interferonov-otgovor</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hiv-infekciata-komprometira-hcv-specificnia-interferonov-otgovor"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/drasticno-uvelicavane-na-cestotata-na-raka-na-cernia-drob-pri-hiv-pozitivnite-s-virusen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/drasticno-uvelicavane-na-cestotata-na-raka-na-cernia-drob-pri-hiv-pozitivnite-s-virusen"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/telaprevir-e-bezopasen-i-efikasen-pri-pacienti-s-koinfekcia-s-hiv-i-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/telaprevir-e-bezopasen-i-efikasen-pri-pacienti-s-koinfekcia-s-hiv-i-hepatit-s"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/danni-ot-registr-pokazvat-ce-lekarstvata-za-hepatit-v-izglezdat-bezopasni-po-vreme-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/danni-ot-registr-pokazvat-ce-lekarstvata-za-hepatit-v-izglezdat-bezopasni-po-vreme-na"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rezultati-ot-izcalo-peroralnata-kombinacia-na-abbott-do-99</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rezultati-ot-izcalo-peroralnata-kombinacia-na-abbott-do-99"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/incivek-telaprevir-preduprezdenie-za-tezki-obrivi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/incivek-telaprevir-preduprezdenie-za-tezki-obrivi"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/v-lekarstvenia-etiket-na-telaprevir-se-dobava-kare-v-cerno-s-preduprezdenie-za-seriozen-kozen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/v-lekarstvenia-etiket-na-telaprevir-se-dobava-kare-v-cerno-s-preduprezdenie-za-seriozen-kozen"/>
  <lastmod>2018-05-12T15:45:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/za-da-eliminirame-khepatit-s-tryabva-da-lekuvame-lishenite-ot-svoboda-i-khorata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/za-da-eliminirame-khepatit-s-tryabva-da-lekuvame-lishenite-ot-svoboda-i-khorata"/>
  <lastmod>2020-10-28T15:43:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/amerikanska-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2012-tenofovir-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/amerikanska-asociacia-za-izucavane-na-cernodrobnite-zabolavania-aasld-2012-tenofovir-e"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nai-vaznite-novini-na-2012</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nai-vaznite-novini-na-2012"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacientite-s-hepatit-b-i-hbeag-serokonversia-po-vreme-na-lecenie-moze-da-namat-dlgotraen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacientite-s-hepatit-b-i-hbeag-serokonversia-po-vreme-na-lecenie-moze-da-namat-dlgotraen"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tiineidzri-vaksinirani-sresu-hepatit-v-kato-bebeta-moze-da-izgubat-imuniteta-si</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tiineidzri-vaksinirani-sresu-hepatit-v-kato-bebeta-moze-da-izgubat-imuniteta-si"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zabolavane-na-cernia-drob-e-vodesa-pricina-za-smrt-pri-horata-s-hronicen-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zabolavane-na-cernia-drob-e-vodesa-pricina-za-smrt-pri-horata-s-hronicen-hepatit-b"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aktualiziraniat-etiket-listovka-na-boceprevir-victrelis-dobava-danni-za-pacienti-neotgovorili</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aktualiziraniat-etiket-listovka-na-boceprevir-victrelis-dobava-danni-za-pacienti-neotgovorili"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-2013-kombinacia-bez-interferon-na-abbvie-lekuva-nad-90-ot-slucaite-na-hepatit-c-genotip-1</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-2013-kombinacia-bez-interferon-na-abbvie-lekuva-nad-90-ot-slucaite-na-hepatit-c-genotip-1"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-2013-ach-3102-i-sovaprevir-sovaprevir-pokazvat-mosno-deistvie-i-visoka-granica-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-2013-ach-3102-i-sovaprevir-sovaprevir-pokazvat-mosno-deistvie-i-visoka-granica-na"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-2013-daclatasvir-asunaprevir-bms-791325-izglezda-obesavasa-kombinacia-bez-interferon</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-2013-daclatasvir-asunaprevir-bms-791325-izglezda-obesavasa-kombinacia-bez-interferon"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/easl-2013-daclatasvir-sofosbuvir-predlaga-spasitelna-terapia-sled-obsoprieto-standartno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/easl-2013-daclatasvir-sofosbuvir-predlaga-spasitelna-terapia-sled-obsoprieto-standartno"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kombinirana-formula-na-sofosbuvirledipasvir-sofosbuvirledipasvir-pokazva-dobr-ranen-otgovor-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kombinirana-formula-na-sofosbuvirledipasvir-sofosbuvirledipasvir-pokazva-dobr-ranen-otgovor-s"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sas-licenzira-prvata-kombinirana-tabletka-za-bezinterferonovo-lecenie-na-hepatit-s-harvoni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sas-licenzira-prvata-kombinirana-tabletka-za-bezinterferonovo-lecenie-na-hepatit-s-harvoni"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatni-skriningovi-izsledvania-za-hepatit-v-i-s-na-izlozenieto-medikus-dento-galenia-v-grad</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatni-skriningovi-izsledvania-za-hepatit-v-i-s-na-izlozenieto-medikus-dento-galenia-v-grad"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novite-peroralni-medikamenti-na-abbvie-poluciha-polozitelno-stanovise-ot-ema</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novite-peroralni-medikamenti-na-abbvie-poluciha-polozitelno-stanovise-ot-ema"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/revolucionno-lecenie-za-hepatit-s-poluci-razresenie-za-upotreba-v-evropa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/revolucionno-lecenie-za-hepatit-s-poluci-razresenie-za-upotreba-v-evropa"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/viekirax-i-exviera-viekira-pak-za-lecenie-na-hepatit-s-genotip-1-sa-vkluceni-v-pozitivnia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/viekirax-i-exviera-viekira-pak-za-lecenie-na-hepatit-s-genotip-1-sa-vkluceni-v-pozitivnia"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sovaldi-i-harvoni-za-lecenie-na-hepatit-s-sa-vkluceni-v-pozitivnia-spisk</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sovaldi-i-harvoni-za-lecenie-na-hepatit-s-sa-vkluceni-v-pozitivnia-spisk"/>
  <lastmod>2018-05-12T15:45:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepaktiv-vze-ucastie-v-obucitelen-seminar-na-tema-virusniat-hepatit-i-tvoeto-talo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepaktiv-vze-ucastie-v-obucitelen-seminar-na-tema-virusniat-hepatit-i-tvoeto-talo"/>
  <lastmod>2018-06-15T22:28:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nzok-se-zaplasa-nai-svremennoto-lecenie-na-pacienti-s-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nzok-se-zaplasa-nai-svremennoto-lecenie-na-pacienti-s-hepatit-s"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/aktualni-kriterii-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/aktualni-kriterii-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvania-pokazvat-ce-lekarite-ne-uspavat-da-diagnosticirat-povece-ot-50-ot-svoite-pacienti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvania-pokazvat-ce-lekarite-ne-uspavat-da-diagnosticirat-povece-ot-50-ot-svoite-pacienti"/>
  <lastmod>2018-06-20T10:59:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/szo-utvrdi-plan-za-eliminirane-na-virusnite-hepatiti-v-evropa-u-nas-svremennoto-lecenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/szo-utvrdi-plan-za-eliminirane-na-virusnite-hepatiti-v-evropa-u-nas-svremennoto-lecenie-na"/>
  <lastmod>2018-06-19T12:48:48+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zalba-ot-pacient-vv-vrzka-s-usloznenata-procedura-po-hospitalizacia-na-pacienti-s-hronicen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zalba-ot-pacient-vv-vrzka-s-usloznenata-procedura-po-hospitalizacia-na-pacienti-s-hronicen"/>
  <lastmod>2018-06-19T12:47:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstvata-sreschu-hcv-mozhe-da-reaktivirat-hbv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstvata-sreschu-hcv-mozhe-da-reaktivirat-hbv"/>
  <lastmod>2019-12-29T08:38:21+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novata-formula-na-tenofovir-predlaga-po-bezopasno-lecenie-na-hepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novata-formula-na-tenofovir-predlaga-po-bezopasno-lecenie-na-hepatit-b"/>
  <lastmod>2018-12-19T18:50:59+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nacionalniat-institut-po-zdravni-grizi-nice-na-obedinenoto-kralstvo-odobri-epclusa-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nacionalniat-institut-po-zdravni-grizi-nice-na-obedinenoto-kralstvo-odobri-epclusa-za"/>
  <lastmod>2018-05-12T14:51:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vodesiat-preparat-sresu-hepatit-b-razrabotvan-ot-contravir-preminava-km-izpitvane-ot-faza-2a</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vodesiat-preparat-sresu-hepatit-b-razrabotvan-ot-contravir-preminava-km-izpitvane-ot-faza-2a"/>
  <lastmod>2018-05-12T14:51:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prvi-pacient-poluci-lambda-kato-terapia-za-hepatit-d-v-izpitvane-ot-faza-2</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prvi-pacient-poluci-lambda-kato-terapia-za-hepatit-d-v-izpitvane-ot-faza-2"/>
  <lastmod>2018-05-12T14:51:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/biomarker-moze-da-opredeli-koi-pacienti-sa-v-risk-ot-recidiv-na-hepatit-b-po-vreme-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/biomarker-moze-da-opredeli-koi-pacienti-sa-v-risk-ot-recidiv-na-hepatit-b-po-vreme-na"/>
  <lastmod>2018-05-12T14:51:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/mrdnisiprsta-i-se-izsledvai-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/mrdnisiprsta-i-se-izsledvai-za-hepatit-s"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/obaviha-pobeditelite-v-zurnalisticeskia-konkurs-svat-bez-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/obaviha-pobeditelite-v-zurnalisticeskia-konkurs-svat-bez-hepatit-s"/>
  <lastmod>2018-12-19T18:50:20+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zarazyavaneto-s-khepatit-v-se-dlzhi-na-prvonachalen-slab-imunen-otgovor</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zarazyavaneto-s-khepatit-v-se-dlzhi-na-prvonachalen-slab-imunen-otgovor"/>
  <lastmod>2019-12-29T08:20:34+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/razrabotvaniat-rezim-glecaprevirpibrentasvir-izglezda-visokoefektiven-pri-pacienti-s-tezko</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/razrabotvaniat-rezim-glecaprevirpibrentasvir-izglezda-visokoefektiven-pri-pacienti-s-tezko"/>
  <lastmod>2018-12-19T18:49:56+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/koinfektiranite-pacienti-s-khivhcv-postigat-visoki-niva-na-izlekuvane-na-khepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/koinfektiranite-pacienti-s-khivhcv-postigat-visoki-niva-na-izlekuvane-na-khepatit-c"/>
  <lastmod>2019-12-29T08:37:55+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstva-generici-za-lecenie-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstva-generici-za-lecenie-na-hepatit-c"/>
  <lastmod>2018-06-19T22:42:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ekstrakhepatalni-sstoyaniya-pri-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ekstrakhepatalni-sstoyaniya-pri-khepatit-s"/>
  <lastmod>2019-12-29T08:26:59+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/genericite-za-lecenie-na-hepatit-c-zakupeni-prez-internet-postigat-visoki-niva-na-izlekuvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/genericite-za-lecenie-na-hepatit-c-zakupeni-prez-internet-postigat-visoki-niva-na-izlekuvane"/>
  <lastmod>2018-12-19T18:44:46+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novini-ot-konferenciata-aasld-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novini-ot-konferenciata-aasld-2016"/>
  <lastmod>2018-12-19T18:44:01+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-alafenamid-poluci-odobrenie-v-evropa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-alafenamid-poluci-odobrenie-v-evropa"/>
  <lastmod>2018-12-19T18:43:08+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/preparatt-lonafarnib-namalava-nivata-na-hepatit-delta-pri-ponosimi-stranicni-efekti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/preparatt-lonafarnib-namalava-nivata-na-hepatit-delta-pri-ponosimi-stranicni-efekti"/>
  <lastmod>2018-12-19T18:42:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/krioglobulinemiya-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/krioglobulinemiya-i-khepatit-s"/>
  <lastmod>2019-12-29T08:32:00+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/plosk-lishey-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/plosk-lishey-i-khepatit-s"/>
  <lastmod>2019-12-29T08:27:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/glomerulonefrit-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/glomerulonefrit-i-khepatit-s"/>
  <lastmod>2019-12-29T08:27:20+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nekhodzhkinov-limfom-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nekhodzhkinov-limfom-i-khepatit-s"/>
  <lastmod>2019-12-29T08:27:09+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/porfiriya-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/porfiriya-i-khepatit-s"/>
  <lastmod>2019-12-29T08:26:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/periferna-nevropatiya-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/periferna-nevropatiya-i-khepatit-s"/>
  <lastmod>2019-12-29T08:26:39+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vaskulit-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vaskulit-i-khepatit-s"/>
  <lastmod>2019-12-29T08:26:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstvena-rezistentnost-i-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstvena-rezistentnost-i-khepatit-s"/>
  <lastmod>2019-12-29T08:26:19+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kakvo-predstavlyavat-ravs-rezistentni-varianti-pri-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kakvo-predstavlyavat-ravs-rezistentni-varianti-pri-khepatit-s"/>
  <lastmod>2019-12-29T08:26:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-v-i-s"/>
  <lastmod>2018-12-19T18:26:55+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novini-za-hepatit-s-mart-2017</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novini-za-hepatit-s-mart-2017"/>
  <lastmod>2018-12-19T18:35:07+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/danni-pokazvat-ce-hepatit-c-se-predava-po-vreme-na-analen-seks-bez-prezervativ</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/danni-pokazvat-ce-hepatit-c-se-predava-po-vreme-na-analen-seks-bez-prezervativ"/>
  <lastmod>2018-12-19T18:34:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/gilead-predstavi-danni-otnosno-vemlidy</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/gilead-predstavi-danni-otnosno-vemlidy"/>
  <lastmod>2018-12-19T18:32:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-proucvane-izsledva-vrzkata-mezdu-virusnite-hepatiti-i-bolestta-na-parkinson</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-proucvane-izsledva-vrzkata-mezdu-virusnite-hepatiti-i-bolestta-na-parkinson"/>
  <lastmod>2018-12-19T18:32:32+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/obzor-na-izbrani-novini-za-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/obzor-na-izbrani-novini-za-khepatit-s"/>
  <lastmod>2019-12-29T08:25:53+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/skriningovi-akcii-na-28-i-29-uli-v-centr-za-seksualno-zdrave-sofia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/skriningovi-akcii-na-28-i-29-uli-v-centr-za-seksualno-zdrave-sofia"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izlizame-vv-vakancia-ocakvaite-ni-otnovo-prez-septemvri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izlizame-vv-vakancia-ocakvaite-ni-otnovo-prez-septemvri"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/scitano-ot-16-oktomvri-pacientite-se-doplasat-za-lecenieto-s-viread</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/scitano-ot-16-oktomvri-pacientite-se-doplasat-za-lecenieto-s-viread"/>
  <lastmod>2018-12-19T18:31:24+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-da-razpoznaete-falsivite-lekarstva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-da-razpoznaete-falsivite-lekarstva"/>
  <lastmod>2018-12-19T18:30:18+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konkurs-na-tema-skrining-za-svat-bez-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konkurs-na-tema-skrining-za-svat-bez-hepatit-c"/>
  <lastmod>2018-12-19T18:29:54+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/evropeiska-sedmica-za-testvane-za-hepatit-v-hepatit-s-i-hiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/evropeiska-sedmica-za-testvane-za-hepatit-v-hepatit-s-i-hiv"/>
  <lastmod>2018-12-19T18:29:38+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/veseli-praznici-ot-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/veseli-praznici-ot-sdruzenie-hepaktiv"/>
  <lastmod>2018-05-12T15:47:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/globalna-kampania-sresu-stigmata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/globalna-kampania-sresu-stigmata"/>
  <lastmod>2018-12-19T18:29:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/imate-li-15-minuti-za-svoeto-zdrave</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/imate-li-15-minuti-za-svoeto-zdrave"/>
  <lastmod>2018-12-19T18:28:47+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/saitt-na-sdruzenie-hepaktiv-vece-e-realnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/saitt-na-sdruzenie-hepaktiv-vece-e-realnost"/>
  <lastmod>2018-06-16T15:39:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/malko-statistika-za-mesec-april</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/malko-statistika-za-mesec-april"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-trsi-prevodaci</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-trsi-prevodaci"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-viread-i-entekavir-baraclude-oficialno-sa-dobaveni-v-pozitivnia-spisk</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-viread-i-entekavir-baraclude-oficialno-sa-dobaveni-v-pozitivnia-spisk"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepaktiv-prie-prvite-si-clenove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepaktiv-prie-prvite-si-clenove"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/balata-kniga-za-hepatit-c-bese-publikuvana-na-saita-na-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/balata-kniga-za-hepatit-c-bese-publikuvana-na-saita-na-hepaktiv"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konferencia-vv-varsava-posvetena-na-hepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konferencia-vv-varsava-posvetena-na-hepatit-c"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/koledno-parti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/koledno-parti"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/statistika-za-publikuvanite-materiali-i-posesaemostta-na-saita-za-izminalata-edna-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/statistika-za-publikuvanite-materiali-i-posesaemostta-na-saita-za-izminalata-edna-godina"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepaktiv-prie-novi-clenove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepaktiv-prie-novi-clenove"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/19-ti-mai-2010-svetoven-den-za-borba-s-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/19-ti-mai-2010-svetoven-den-za-borba-s-hepatita"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-se-vkluci-v-kampania-na-svetovnia-hepatiten-alians</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-se-vkluci-v-kampania-na-svetovnia-hepatiten-alians"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/28-mi-uli-2011-svetoven-den-za-borba-s-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/28-mi-uli-2011-svetoven-den-za-borba-s-hepatita"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/listovki-s-informacia-za-virusnite-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/listovki-s-informacia-za-virusnite-hepatiti"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-vece-e-clen-na-elpa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-vece-e-clen-na-elpa"/>
  <lastmod>2018-06-16T21:28:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/poslednite-aktivnosti-na-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/poslednite-aktivnosti-na-sdruzenie-hepaktiv"/>
  <lastmod>2018-04-27T17:06:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/predstavane-na-knigata-pozitivno-na-toska-ivanova</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/predstavane-na-knigata-pozitivno-na-toska-ivanova"/>
  <lastmod>2018-06-16T21:28:39+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-organizira-prvite-grupi-za-podkrepa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-organizira-prvite-grupi-za-podkrepa"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zapocva-mesect-na-bezplatno-testvane-za-hepatit-s-v-calata-strana</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zapocva-mesect-na-bezplatno-testvane-za-hepatit-s-v-calata-strana"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pokana-za-ucastie-v-obso-sbranie-na-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pokana-za-ucastie-v-obso-sbranie-na-sdruzenie-hepaktiv"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepaktiv-prie-porednite-novi-clenove</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepaktiv-prie-porednite-novi-clenove"/>
  <lastmod>2018-05-12T15:41:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/grupite-za-podkrepa-se-se-provezdat-v-nova-zala</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/grupite-za-podkrepa-se-se-provezdat-v-nova-zala"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/blgaria-e-na-21-vo-masto-po-otnosenie-na-kacestvo-na-grizata-za-pacienta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/blgaria-e-na-21-vo-masto-po-otnosenie-na-kacestvo-na-grizata-za-pacienta"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izpolzvane-na-predvaritelno-naplnena-pisalka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izpolzvane-na-predvaritelno-naplnena-pisalka"/>
  <lastmod>2018-03-22T19:14:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/poslednata-sresa-za-2012-na-grupite-za-podkrepa-se-se-sluci-na-28-dekemvri-petk</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/poslednata-sresa-za-2012-na-grupite-za-podkrepa-se-se-sluci-na-28-dekemvri-petk"/>
  <lastmod>2018-03-31T22:55:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/cestita-nova-2013-ta-godina</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/cestita-nova-2013-ta-godina"/>
  <lastmod>2018-03-31T22:55:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nacionalna-skriningova-kampania-za-ranno-otkrivane-diagnostika-i-lecenie-na-hronicen-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nacionalna-skriningova-kampania-za-ranno-otkrivane-diagnostika-i-lecenie-na-hronicen-hepatit-s"/>
  <lastmod>2018-03-31T22:55:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/grupite-za-podkrepa-za-pacienti-s-hepatit-i-tehnite-blizki-prodlzavat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/grupite-za-podkrepa-za-pacienti-s-hepatit-i-tehnite-blizki-prodlzavat"/>
  <lastmod>2018-03-31T22:55:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zalba-po-povod-statia-vv-v-monitor-ot-7-oktomvri-2013-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zalba-po-povod-statia-vv-v-monitor-ot-7-oktomvri-2013-g"/>
  <lastmod>2018-06-16T21:29:02+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lecenieto-na-hronicen-hepatit-vece-e-dostpno-i-za-deca</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lecenieto-na-hronicen-hepatit-vece-e-dostpno-i-za-deca"/>
  <lastmod>2018-03-31T22:55:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/startira-nacionalna-i-evropeiska-informacionna-kampania-za-borba-s-hepatita-informirai-se</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/startira-nacionalna-i-evropeiska-informacionna-kampania-za-borba-s-hepatita-informirai-se"/>
  <lastmod>2018-06-16T21:29:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/revolucionna-terapia-za-lecenie-na-hepatit-s-bese-predstavena-vv-varna</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/revolucionna-terapia-za-lecenie-na-hepatit-s-bese-predstavena-vv-varna"/>
  <lastmod>2018-06-20T11:00:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-alarmira-zdravnata-kasa-otnosno-problemni-dostavki-na-preparat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-alarmira-zdravnata-kasa-otnosno-problemni-dostavki-na-preparat"/>
  <lastmod>2018-06-15T17:11:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/90-ot-blgarite-ne-znaat-kakva-tocno-bolest-e-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/90-ot-blgarite-ne-znaat-kakva-tocno-bolest-e-hepatit-s"/>
  <lastmod>2018-06-19T12:42:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/hepaktiv-i-hepasist-startiraha-prvite-si-obucitelni-seminari-na-tema-virusni-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/hepaktiv-i-hepasist-startiraha-prvite-si-obucitelni-seminari-na-tema-virusni-hepatiti"/>
  <lastmod>2018-06-16T21:33:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sluzitelite-u-nas-masovo-ne-se-izsledvat-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sluzitelite-u-nas-masovo-ne-se-izsledvat-za-hepatit-s"/>
  <lastmod>2018-06-16T21:56:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dzon-loutn-ot-uraa-hiip-podari-pesen-na-kampaniata-hepi-li-si</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dzon-loutn-ot-uraa-hiip-podari-pesen-na-kampaniata-hepi-li-si"/>
  <lastmod>2018-06-16T21:56:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-alarmira-drzavnite-institucii-otnosno-problem-s-nalicnostta-na-preparata</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-alarmira-drzavnite-institucii-otnosno-problem-s-nalicnostta-na-preparata"/>
  <lastmod>2018-06-15T17:09:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/korespondencia-s-instituciite-otnosno-lipsata-na-viread</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/korespondencia-s-instituciite-otnosno-lipsata-na-viread"/>
  <lastmod>2018-06-15T17:08:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pismo-v-podkrepa-na-bezinterferonovite-terapii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pismo-v-podkrepa-na-bezinterferonovite-terapii"/>
  <lastmod>2018-06-15T17:10:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otvoreno-pismo-do-ministr-moskov-otnosno-slivaneto-na-umbal-svivan-rilski-s-umbal</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otvoreno-pismo-do-ministr-moskov-otnosno-slivaneto-na-umbal-svivan-rilski-s-umbal"/>
  <lastmod>2018-06-15T17:10:28+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/doklad-za-deinostta-2014-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/doklad-za-deinostta-2014-g"/>
  <lastmod>2018-06-19T16:01:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-vze-ucastie-v-preskonferencia-na-tema-hronicniat-hepatit-s-vece-se-lekuva</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-vze-ucastie-v-preskonferencia-na-tema-hronicniat-hepatit-s-vece-se-lekuva"/>
  <lastmod>2018-06-16T21:36:32+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/svetoven-den-za-borba-s-hepatita-28072015</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/svetoven-den-za-borba-s-hepatita-28072015"/>
  <lastmod>2018-06-16T21:56:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/start-na-kampaniata-841-glasa-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/start-na-kampaniata-841-glasa-za-hepatit-s"/>
  <lastmod>2018-06-16T21:55:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otgovor-ot-ministerstvo-na-zdraveopazvaneto-otnosno-novite-bezinterferonovi-terapii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otgovor-ot-ministerstvo-na-zdraveopazvaneto-otnosno-novite-bezinterferonovi-terapii"/>
  <lastmod>2018-06-16T21:38:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/koncert-po-povod-svetovnia-den-za-borba-s-hepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/koncert-po-povod-svetovnia-den-za-borba-s-hepatita"/>
  <lastmod>2018-06-16T21:39:07+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otbelazvane-na-svetovnia-den-za-borba-s-hepatita-28-uli-2015-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otbelazvane-na-svetovnia-den-za-borba-s-hepatita-28-uli-2015-g"/>
  <lastmod>2018-06-16T21:39:19+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-izprati-oficialno-zapitvane-km-nzok-otnosno-kriteriite-za-lecenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-izprati-oficialno-zapitvane-km-nzok-otnosno-kriteriite-za-lecenie-na"/>
  <lastmod>2018-06-16T21:39:32+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacienti-s-hepatit-s-moze-da-ne-doziveat-do-reimbursaciata-na-novo-lecenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacienti-s-hepatit-s-moze-da-ne-doziveat-do-reimbursaciata-na-novo-lecenie"/>
  <lastmod>2018-06-16T21:39:48+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otgovor-ot-zdravnata-kasa-otnosno-bezinterferonovite-terapii-za-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otgovor-ot-zdravnata-kasa-otnosno-bezinterferonovite-terapii-za-hepatit-s"/>
  <lastmod>2018-06-16T21:40:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/doklad-za-deinostta-2015-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/doklad-za-deinostta-2015-g"/>
  <lastmod>2018-06-19T16:01:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekuvat-li-se-vece-pacienti-s-novite-bezinterferonovi-terapii-za-hcv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekuvat-li-se-vece-pacienti-s-novite-bezinterferonovi-terapii-za-hcv"/>
  <lastmod>2018-06-16T21:40:21+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-vze-ucastie-na-2-vazni-cernodrobni-konferencii-prez-april-2016</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-vze-ucastie-na-2-vazni-cernodrobni-konferencii-prez-april-2016"/>
  <lastmod>2018-06-19T14:16:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/svat-bez-hepatit-s-realnost-ili-mecta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/svat-bez-hepatit-s-realnost-ili-mecta"/>
  <lastmod>2018-06-20T10:58:34+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacientsko-sdruzhenie-khepaktiv-predlaga-vazhno-izmenenie-na-normativnata-uredba-kasaescha</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacientsko-sdruzhenie-khepaktiv-predlaga-vazhno-izmenenie-na-normativnata-uredba-kasaescha"/>
  <lastmod>2020-02-11T19:02:35+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-na-2-ri-i-3-ti-uli-v-blagoevgrad</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-na-2-ri-i-3-ti-uli-v-blagoevgrad"/>
  <lastmod>2018-06-16T21:42:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatnite-izsledvania-za-hepatit-prodlzavat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatnite-izsledvania-za-hepatit-prodlzavat"/>
  <lastmod>2018-06-16T21:43:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ela-i-se-izsledvai-za-hepatit-po-povod-svetovnia-den-za-borba-s-nego</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ela-i-se-izsledvai-za-hepatit-po-povod-svetovnia-den-za-borba-s-nego"/>
  <lastmod>2018-12-19T18:53:33+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izlizame-na-protest</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izlizame-na-protest"/>
  <lastmod>2018-12-19T18:53:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacienti-s-hepatit-s-smrtnata-ni-prisda-e-proiznesena-vece-ima-pocinali-poradi-zabavane-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacienti-s-hepatit-s-smrtnata-ni-prisda-e-proiznesena-vece-ima-pocinali-poradi-zabavane-na"/>
  <lastmod>2018-12-19T18:52:48+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/imate-zabaven-dostp-do-bezinterferonovoto-lecenie-za-hepatit-s-podaite-zalba</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/imate-zabaven-dostp-do-bezinterferonovoto-lecenie-za-hepatit-s-podaite-zalba"/>
  <lastmod>2018-12-19T18:52:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nova-usluga-za-bezplatno-izsledvane-za-hepatit-s-v-sofia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nova-usluga-za-bezplatno-izsledvane-za-hepatit-s-v-sofia"/>
  <lastmod>2018-12-19T18:50:38+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zapoznahme-i-ombudsmana-na-rblgaria-s-nastoasite-iziskvania-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zapoznahme-i-ombudsmana-na-rblgaria-s-nastoasite-iziskvania-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-12-19T18:45:09+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ne-lekarite-nzok-se-opredela-s-koi-medikament-se-se-lekuvat-pacientite-s-hepatit-s-porednoto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ne-lekarite-nzok-se-opredela-s-koi-medikament-se-se-lekuvat-pacientite-s-hepatit-s-porednoto"/>
  <lastmod>2018-12-19T18:49:13+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-obzalva-pred-vas-prietite-kriterii-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-obzalva-pred-vas-prietite-kriterii-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-12-19T18:47:51+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-mediite-otrazavat-kazusa-ikonomiceska-celesobraznost-pri-lecenieto-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-mediite-otrazavat-kazusa-ikonomiceska-celesobraznost-pri-lecenieto-na-hepatit-s"/>
  <lastmod>2018-12-19T18:47:29+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/porednata-zalba-na-pacient-cakas-lecenie-za-hepatit-s-vece-6-ti-mesec</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/porednata-zalba-na-pacient-cakas-lecenie-za-hepatit-s-vece-6-ti-mesec"/>
  <lastmod>2018-12-19T18:46:01+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vhodirahme-zalba-vv-vas-s-iskane-za-otmana-na-nastoasite-kriterii-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vhodirahme-zalba-vv-vas-s-iskane-za-otmana-na-nastoasite-kriterii-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-12-19T18:45:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzmoznost-za-prisedinavane-na-pacienti-km-nasata-zalba-sresu-iziskvaniata-za-lecenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzmoznost-za-prisedinavane-na-pacienti-km-nasata-zalba-sresu-iziskvaniata-za-lecenie-na"/>
  <lastmod>2018-12-19T18:43:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spryakhme-deystvieto-na-novite-kriterii-za-lechenie-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spryakhme-deystvieto-na-novite-kriterii-za-lechenie-na-khepatit-s"/>
  <lastmod>2020-01-11T21:07:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ot-1-mart-vlazoha-v-sila-novite-iziskvania-za-lecenie-na-hepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ot-1-mart-vlazoha-v-sila-novite-iziskvania-za-lecenie-na-hepatit-s"/>
  <lastmod>2018-12-19T18:35:45+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ot-1-vi-april-se-vzstanovava-polucaneto-na-viread-bez-doplasane-ot-strana-na-pacientite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ot-1-vi-april-se-vzstanovava-polucaneto-na-viread-bez-doplasane-ot-strana-na-pacientite"/>
  <lastmod>2018-12-19T18:35:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dostpt-do-testove-i-lecenie-na-hepatit-s-v-evropeiskite-zatvori-trabva-da-se-podobri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dostpt-do-testove-i-lecenie-na-hepatit-s-v-evropeiskite-zatvori-trabva-da-se-podobri"/>
  <lastmod>2018-12-19T18:23:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konkurs-za-zurnalisticeski-material-na-tema-blgaria-bez-hepatit-c-realnost-ili-utopia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konkurs-za-zurnalisticeski-material-na-tema-blgaria-bez-hepatit-c-realnost-ili-utopia"/>
  <lastmod>2018-12-19T18:23:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/checkpoint-sofia-ucastva-v-regionalna-sresa-v-lublana</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/checkpoint-sofia-ucastva-v-regionalna-sresa-v-lublana"/>
  <lastmod>2018-12-19T18:22:51+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/132-coveka-se-izsledvaha-bezplatno-za-hepatit-v-i-s-v-grad-smolan</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/132-coveka-se-izsledvaha-bezplatno-za-hepatit-v-i-s-v-grad-smolan"/>
  <lastmod>2018-12-19T18:22:14+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvahme-136-coveka-za-hepatit-v-i-s-6-ot-koito-s-polozitelen-rezultat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvahme-136-coveka-za-hepatit-v-i-s-6-ot-koito-s-polozitelen-rezultat"/>
  <lastmod>2018-12-19T18:21:56+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-na-10-i-septemvri-v-gr-sumen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatni-izsledvania-za-hepatit-na-10-i-septemvri-v-gr-sumen"/>
  <lastmod>2018-12-19T18:26:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvahme-rekorden-broi-hora-za-hepatit-v-i-s-v-sumen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvahme-rekorden-broi-hora-za-hepatit-v-i-s-v-sumen"/>
  <lastmod>2018-12-19T18:25:58+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvaite-se-za-hepatit-v-i-s-na-8-oktomvri-v-stara-zagora</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvaite-se-za-hepatit-v-i-s-na-8-oktomvri-v-stara-zagora"/>
  <lastmod>2018-12-19T18:25:46+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rekorden-broi-hora-se-izsledvaha-za-hepatit-v-i-s-v-stara-zagora</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rekorden-broi-hora-se-izsledvaha-za-hepatit-v-i-s-v-stara-zagora"/>
  <lastmod>2018-12-19T18:25:35+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rekorden-broi-pozitivni-rezultati-pri-akciata-ni-v-krdzali</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rekorden-broi-pozitivni-rezultati-pri-akciata-ni-v-krdzali"/>
  <lastmod>2018-12-19T18:25:22+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/preskonferencia-po-povod-evropeiska-sedmica-za-testvane-za-hiv-i-hepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/preskonferencia-po-povod-evropeiska-sedmica-za-testvane-za-hiv-i-hepatiti"/>
  <lastmod>2018-12-19T18:25:00+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/obavihme-pobeditelite-v-zurnalisticeskia-konkurs-blgaria-bez-hepatit-c-realnost-ili-utopia</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/obavihme-pobeditelite-v-zurnalisticeskia-konkurs-blgaria-bez-hepatit-c-realnost-ili-utopia"/>
  <lastmod>2018-12-19T18:24:46+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzenie-hepaktiv-zakriva-svoite-grupi-za-podkrepa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzenie-hepaktiv-zakriva-svoite-grupi-za-podkrepa"/>
  <lastmod>2019-01-14T15:16:47+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pokana-za-obso-sbranie-na-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pokana-za-obso-sbranie-na-sdruzenie-hepaktiv"/>
  <lastmod>2019-01-16T08:32:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lechenieto-po-vreme-na-bremennost-izchistva-virusa-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lechenieto-po-vreme-na-bremennost-izchistva-virusa-na-khepatit-s"/>
  <lastmod>2019-12-29T08:24:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/napredk-v-opitite-da-se-izlekuva-khepatit-b-otdavna-prenebregnatiya-bich-za-milioni-khora</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/napredk-v-opitite-da-se-izlekuva-khepatit-b-otdavna-prenebregnatiya-bich-za-milioni-khora"/>
  <lastmod>2019-12-29T08:19:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ot-15-april-vlizat-v-sila-novite-iziskvaniya-za-lechenie-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ot-15-april-vlizat-v-sila-novite-iziskvaniya-za-lechenie-na-khepatit-s"/>
  <lastmod>2020-05-04T19:27:10+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bum-na-predavaneto-na-khepatit-s-po-seksualen-pt-pri-gey-mzhe-ss-ili-bez-khiv-infekciya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bum-na-predavaneto-na-khepatit-s-po-seksualen-pt-pri-gey-mzhe-ss-ili-bez-khiv-infekciya"/>
  <lastmod>2020-05-11T12:10:46+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rumniya-s-ambiciozen-plan-za-eliminaciya-na-hepatit-c-do-2030-g</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rumniya-s-ambiciozen-plan-za-eliminaciya-na-hepatit-c-do-2030-g"/>
  <lastmod>2019-05-08T20:34:31+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nevezhestvoto-i-stigmata-vzeha-porednata-si-zhertva-v-bulgariya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nevezhestvoto-i-stigmata-vzeha-porednata-si-zhertva-v-bulgariya"/>
  <lastmod>2019-05-12T10:24:29+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/poredniyat-krvodaritel-s-khepatit-s-koyto-4-godini-ne-e-uvedomen-ot-nctkh-za-svoya-rezultat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/poredniyat-krvodaritel-s-khepatit-s-koyto-4-godini-ne-e-uvedomen-ot-nctkh-za-svoya-rezultat"/>
  <lastmod>2019-12-13T11:32:24+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/rust-na-infekciite-s-hronichen-hepatit-b-ot-2008-g-nasam</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/rust-na-infekciite-s-hronichen-hepatit-b-ot-2008-g-nasam"/>
  <lastmod>2019-12-13T11:31:49+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lek-spad-v-diagnosticiranite-sluchai-na-hepatit-s-prez-2017</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lek-spad-v-diagnosticiranite-sluchai-na-hepatit-s-prez-2017"/>
  <lastmod>2019-12-13T11:31:29+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/startira-kampaniyata-hepatit%D0%B0t-chesto-e-nevidim-izsledvay-se-sega</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/startira-kampaniyata-hepatit%D0%B0t-chesto-e-nevidim-izsledvay-se-sega"/>
  <lastmod>2021-01-23T13:41:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/90-ot-infektiranite-s-khepatit-s-ne-podozirat-za-nalichieto-na-virusa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/90-ot-infektiranite-s-khepatit-s-ne-podozirat-za-nalichieto-na-virusa"/>
  <lastmod>2019-12-13T11:30:55+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/toshka-ivanova-koyato-pomaga-na-bolnite-ot-khepatit-da-se-preboryat-s-bolestta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/toshka-ivanova-koyato-pomaga-na-bolnite-ot-khepatit-da-se-preboryat-s-bolestta"/>
  <lastmod>2019-12-13T11:30:32+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/za-tri-dni-izsledvakhme-995-choveka-za-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/za-tri-dni-izsledvakhme-995-choveka-za-khepatit-v-i-s"/>
  <lastmod>2019-12-13T11:29:34+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prodlzhavat-bezplatnite-izsledvaniya-za-khepatit-v-i-s-v-ramkite-na-kampaniyata-khepatitt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prodlzhavat-bezplatnite-izsledvaniya-za-khepatit-v-i-s-v-ramkite-na-kampaniyata-khepatitt"/>
  <lastmod>2019-12-13T11:29:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/blizo-1700-choveka-byakha-izsledvani-bezplatno-v-ramkite-na-kampaniyata-khepatitt-chesto-e</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/blizo-1700-choveka-byakha-izsledvani-bezplatno-v-ramkite-na-kampaniyata-khepatitt-chesto-e"/>
  <lastmod>2019-12-13T11:28:58+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/podadokhme-zhalba-sreschu-novite-iziskvaniya-za-lechenie-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/podadokhme-zhalba-sreschu-novite-iziskvaniya-za-lechenie-na-khepatit-s"/>
  <lastmod>2019-12-13T11:26:41+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/eksperimentalna-vaksina-sreschu-khepatit-s-ne-uspyava-da-predotvrati-infektiraneto-s-virusa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/eksperimentalna-vaksina-sreschu-khepatit-s-ne-uspyava-da-predotvrati-infektiraneto-s-virusa"/>
  <lastmod>2019-12-13T11:26:24+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/fda-odobri-pangenotipno-lechenie-za-khepatit-s-koeto-sksyava-terapiyata-do-osem-sedmici</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/fda-odobri-pangenotipno-lechenie-za-khepatit-s-koeto-sksyava-terapiyata-do-osem-sedmici"/>
  <lastmod>2020-12-09T19:18:16+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otbelyazvame-za-poredna-godina-evropeyskata-sedmica-za-testvane-za-khiv-i-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otbelyazvame-za-poredna-godina-evropeyskata-sedmica-za-testvane-za-khiv-i-khepatit"/>
  <lastmod>2019-12-13T11:25:44+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ekipt-na-sdruzhenie-khepaktiv-vi-zhelae-topli-praznichni-dni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ekipt-na-sdruzhenie-khepaktiv-vi-zhelae-topli-praznichni-dni"/>
  <lastmod>2019-12-20T12:29:17+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chernodrobnata-biopsiya-otpadna-kato-zadlzhitelno-iziskvane-pri-otpuskane-na-lechenie-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chernodrobnata-biopsiya-otpadna-kato-zadlzhitelno-iziskvane-pri-otpuskane-na-lechenie-za"/>
  <lastmod>2020-01-15T11:24:33+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ot-10-fevruari-sigurnostta-na-darenata-krv-sche-se-povishi-chrez-izsledvane-s-nat-tekhnologiya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ot-10-fevruari-sigurnostta-na-darenata-krv-sche-se-povishi-chrez-izsledvane-s-nat-tekhnologiya"/>
  <lastmod>2020-02-11T20:18:52+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pregledayte-cherniya-si-drob-ako-prekalyavate-ss-sladkoto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pregledayte-cherniya-si-drob-ako-prekalyavate-ss-sladkoto"/>
  <lastmod>2020-02-17T12:37:11+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/preustanovyavame-vremenno-lichnite-konsultacii-i-izsledvaniyata-za-khepatit-i-khiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/preustanovyavame-vremenno-lichnite-konsultacii-i-izsledvaniyata-za-khepatit-i-khiv"/>
  <lastmod>2020-03-13T19:55:39+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nzok-vvezhda-oblekchena-organizaciya-za-otpuskane-na-lekarstva-pri-khronichno-bolni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nzok-vvezhda-oblekchena-organizaciya-za-otpuskane-na-lekarstva-pri-khronichno-bolni"/>
  <lastmod>2020-03-16T21:06:26+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/v-pomosch-na-pacientite-s-khepatit-virtualni-konsultacii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/v-pomosch-na-pacientite-s-khepatit-virtualni-konsultacii"/>
  <lastmod>2020-03-19T08:52:22+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vsichki-na-vzrast-ot-18-do-79-g-tryabva-da-bdat-testvani-za-khepatit-s-glasi-nova-preporka</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vsichki-na-vzrast-ot-18-do-79-g-tryabva-da-bdat-testvani-za-khepatit-s-glasi-nova-preporka"/>
  <lastmod>2020-05-11T12:09:23+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/agenciyata-po-khranite-i-lekarstvata-v-sasch-dade-zelena-svetlina-za-izpolzvaneto-na-epclusa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/agenciyata-po-khranite-i-lekarstvata-v-sasch-dade-zelena-svetlina-za-izpolzvaneto-na-epclusa"/>
  <lastmod>2020-09-13T08:53:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pri-khorata-zhiveeschi-s-khiv-i-ss-steatoza-na-cherniya-drob-ima-visok-risk-ot-razvitie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pri-khorata-zhiveeschi-s-khiv-i-ss-steatoza-na-cherniya-drob-ima-visok-risk-ot-razvitie-na"/>
  <lastmod>2020-09-13T08:55:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/v-po-visok-risk-li-sa-khorata-s-khronichni-chernodrobni-zabolyavaniya-ot-razvitie-na-tezhki</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/v-po-visok-risk-li-sa-khorata-s-khronichni-chernodrobni-zabolyavaniya-ot-razvitie-na-tezhki"/>
  <lastmod>2020-05-11T12:08:48+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/preporki-svrzani-s-korona-virus-sars-cov-2covid-19-za-pacienti-s-virusen-khepatit-ili</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/preporki-svrzani-s-korona-virus-sars-cov-2covid-19-za-pacienti-s-virusen-khepatit-ili"/>
  <lastmod>2020-05-11T12:08:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/poluchikhme-darenie-ot-dezinfekciraschi-i-khigienni-konsumativi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/poluchikhme-darenie-ot-dezinfekciraschi-i-khigienni-konsumativi"/>
  <lastmod>2020-04-24T18:48:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chernodrobnata-steatoza-mozhe-da-povishi-riska-ot-po-tezhko-protichane-na-covid-19</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chernodrobnata-steatoza-mozhe-da-povishi-riska-ot-po-tezhko-protichane-na-covid-19"/>
  <lastmod>2020-07-07T16:21:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pryako-nablyudavanoto-lechenie-na-khepatit-s-visoko-efektivno-pri-khorata-upotrebyavaschi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pryako-nablyudavanoto-lechenie-na-khepatit-s-visoko-efektivno-pri-khorata-upotrebyavaschi"/>
  <lastmod>2020-05-11T12:03:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chernodrobnata-fibroza-se-asociira-s-edin-tip-srdechna-nedostatchnost-bez-znachenie-ot-statusa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chernodrobnata-fibroza-se-asociira-s-edin-tip-srdechna-nedostatchnost-bez-znachenie-ot-statusa"/>
  <lastmod>2020-09-13T08:55:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-imunnata-sistema-reagira-na-virusite-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-imunnata-sistema-reagira-na-virusite-na-khepatit-s"/>
  <lastmod>2020-05-11T12:02:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/perioperativno-protichane-na-covid-19-pri-pacienti-s-chernodrobna-transplantaciya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/perioperativno-protichane-na-covid-19-pri-pacienti-s-chernodrobna-transplantaciya"/>
  <lastmod>2020-05-11T12:04:52+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/osnovni-momenti-v-lechenieto-na-pacienti-s-avtoimunni-chernodrobni-zabolyavaniya-po-vreme-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/osnovni-momenti-v-lechenieto-na-pacienti-s-avtoimunni-chernodrobni-zabolyavaniya-po-vreme-na"/>
  <lastmod>2020-05-11T17:59:31+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstvoto-sreschu-khepatit-v-na-kompaniyata-vir-gotovo-za-kombinirani-izpitvaniya-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstvoto-sreschu-khepatit-v-na-kompaniyata-vir-gotovo-za-kombinirani-izpitvaniya-i-s"/>
  <lastmod>2020-05-11T17:49:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bezplatni-izsledvaniya-za-khepatit-s-v-umbal-sv-ivan-rilski-sofiya-mezhdu-18-i-29-may</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bezplatni-izsledvaniya-za-khepatit-s-v-umbal-sv-ivan-rilski-sofiya-mezhdu-18-i-29-may"/>
  <lastmod>2020-05-23T10:21:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pokachvaneto-na-teglo-sled-uspeshno-lechenie-na-khepatit-s-e-obichayno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pokachvaneto-na-teglo-sled-uspeshno-lechenie-na-khepatit-s-e-obichayno"/>
  <lastmod>2020-06-22T16:06:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/visoka-smrtnost-svrzana-s-covid-19-sred-khorata-s-chernodrobni-zabolyavaniya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/visoka-smrtnost-svrzana-s-covid-19-sred-khorata-s-chernodrobni-zabolyavaniya"/>
  <lastmod>2020-06-22T16:28:53+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dali-viread-po-bezopasen-ot-baraclude-pri-lechenieto-na-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dali-viread-po-bezopasen-ot-baraclude-pri-lechenieto-na-khepatit-v"/>
  <lastmod>2020-06-22T16:37:24+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prouchvane-sred-mishki-ss-zatlstyavane-pokazva-che-fizicheskite-uprazhneniya-pomagat-za</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prouchvane-sred-mishki-ss-zatlstyavane-pokazva-che-fizicheskite-uprazhneniya-pomagat-za"/>
  <lastmod>2020-09-12T10:47:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/terapiya-s-aspirin-namalyava-riska-ot-khepatocelularen-karcinom-svrzan-s-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/terapiya-s-aspirin-namalyava-riska-ot-khepatocelularen-karcinom-svrzan-s-khepatit-s"/>
  <lastmod>2020-07-07T16:37:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vsichko-e-dobre-kogato-zapochva-navreme</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vsichko-e-dobre-kogato-zapochva-navreme"/>
  <lastmod>2020-07-24T19:02:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-v-istoriyata-na-silvana</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-v-istoriyata-na-silvana"/>
  <lastmod>2020-08-04T13:08:22+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-s-istoriyata-na-ivaylo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-s-istoriyata-na-ivaylo"/>
  <lastmod>2020-08-04T13:08:44+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lekarstva-za-khepatit-s-mogat-da-se-okazhat-neskpa-opciya-za-lechenie-na-covid-19</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lekarstva-za-khepatit-s-mogat-da-se-okazhat-neskpa-opciya-za-lechenie-na-covid-19"/>
  <lastmod>2020-08-20T15:22:27+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chernodrobnata-steatoza-se-sluchva-po-ryadko-no-proticha-po-tezhko-pri-zhenite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chernodrobnata-steatoza-se-sluchva-po-ryadko-no-proticha-po-tezhko-pri-zhenite"/>
  <lastmod>2020-09-12T10:47:32+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novi-preporki-na-szo-za-prevenciya-na-predavaneto-na-khepatit-v-ot-mayka-na-dete</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novi-preporki-na-szo-za-prevenciya-na-predavaneto-na-khepatit-v-ot-mayka-na-dete"/>
  <lastmod>2020-09-13T08:54:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konsumaciyata-na-kafe-pomaga-pri-nealkokholnata-steatoza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konsumaciyata-na-kafe-pomaga-pri-nealkokholnata-steatoza"/>
  <lastmod>2020-09-14T10:07:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/cheren-drob-infektiran-s-khepatit-s-mozhe-uspeshno-da-bde-transplantiran</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/cheren-drob-infektiran-s-khepatit-s-mozhe-uspeshno-da-bde-transplantiran"/>
  <lastmod>2020-09-09T15:07:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/poredna-zhalba-vv-vas-sreschu-iziskvaniyata-na-nzok-za-lechenie-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/poredna-zhalba-vv-vas-sreschu-iziskvaniyata-na-nzok-za-lechenie-na-khepatit-s"/>
  <lastmod>2020-11-11T17:12:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spirane-na-priema-na-antivirusni-preparati-mozhe-bi-e-shans-za-izlekuvane-na-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spirane-na-priema-na-antivirusni-preparati-mozhe-bi-e-shans-za-izlekuvane-na-khepatit-v"/>
  <lastmod>2021-01-28T12:20:35+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/modeli-za-predskazvane-na-rak-na-cherniya-drob-pri-khora-izlekuvani-ot-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/modeli-za-predskazvane-na-rak-na-cherniya-drob-pri-khora-izlekuvani-ot-khepatit-s"/>
  <lastmod>2021-01-28T12:20:18+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pri-klinichno-prouchvane-jnj-3989-postiga-ustoychivo-namalyavane-na-povrkhnostniya-antigen-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pri-klinichno-prouchvane-jnj-3989-postiga-ustoychivo-namalyavane-na-povrkhnostniya-antigen-na"/>
  <lastmod>2021-01-28T12:20:53+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-lechenie-za-khepatit-delta-e-odobreno-ot-evropeyskata-komisiya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-lechenie-za-khepatit-delta-e-odobreno-ot-evropeyskata-komisiya"/>
  <lastmod>2021-01-28T12:21:08+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/VAS-za-poreden-put-otsudi-v-polza-na-pacientite-s-hepatit-C</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/VAS-za-poreden-put-otsudi-v-polza-na-pacientite-s-hepatit-C"/>
  <lastmod>2021-01-28T12:21:22+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/schitano-ot-16-noemvri-vlizat-v-sila-novi-usloviya-za-poluchavane-na-medikamenti-za-lechenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/schitano-ot-16-noemvri-vlizat-v-sila-novi-usloviya-za-poluchavane-na-medikamenti-za-lechenie"/>
  <lastmod>2021-01-28T12:21:46+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/fibroskan-ili-chernodrobna-biopsiya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/fibroskan-ili-chernodrobna-biopsiya"/>
  <lastmod>2021-01-28T12:18:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sled-lechenieto-za-khepatit-s-sega-nakde</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sled-lechenieto-za-khepatit-s-sega-nakde"/>
  <lastmod>2020-11-18T18:55:58+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/neobkhodimi-sa-zakonovi-promeni-za-da-se-postigne-efektivna-prevenciya-na-khiv-khepatit-i</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/neobkhodimi-sa-zakonovi-promeni-za-da-se-postigne-efektivna-prevenciya-na-khiv-khepatit-i"/>
  <lastmod>2020-12-01T13:22:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/samo-edna-ot-vseki-chetiri-strani-s-visok-dokhod-se-dvizhi-po-grafik-km-eliminiraneto-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/samo-edna-ot-vseki-chetiri-strani-s-visok-dokhod-se-dvizhi-po-grafik-km-eliminiraneto-na"/>
  <lastmod>2021-01-28T12:09:58+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nov-instrument-predskazva-posledstviyata-ot-ciroza-na-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nov-instrument-predskazva-posledstviyata-ot-ciroza-na-cherniya-drob"/>
  <lastmod>2021-01-28T12:09:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zascho-vse-osche-nyama-vaksina-sreschu-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zascho-vse-osche-nyama-vaksina-sreschu-khepatit-s"/>
  <lastmod>2021-01-28T12:09:22+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-s-mezhdu-nobelovata-nagrada-i-usloviyata-na-zdravnata-kasa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-s-mezhdu-nobelovata-nagrada-i-usloviyata-na-zdravnata-kasa"/>
  <lastmod>2021-01-28T12:09:04+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prekratyava-se-upotrebata-na-telbivudin-sebivo-v-blgariya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prekratyava-se-upotrebata-na-telbivudin-sebivo-v-blgariya"/>
  <lastmod>2021-01-27T16:48:10+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/udlzhava-se-srokt-na-deystvie-na-protokolite-za-skpostruvascho-lechenie-do-30-april-2021</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/udlzhava-se-srokt-na-deystvie-na-protokolite-za-skpostruvascho-lechenie-do-30-april-2021"/>
  <lastmod>2021-01-28T11:25:37+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/eksperimentalni-terapii-za-nealkokholen-steatokhepatit-predstaveni-na-aasld-liver-meeting</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/eksperimentalni-terapii-za-nealkokholen-steatokhepatit-predstaveni-na-aasld-liver-meeting"/>
  <lastmod>2021-01-28T18:21:34+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/visoka-stepen-na-razprostranenie-i-sluchai-na-khepatit-s-sred-mzhe-koito-pravyat-seks-s-mzhe</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/visoka-stepen-na-razprostranenie-i-sluchai-na-khepatit-s-sred-mzhe-koito-pravyat-seks-s-mzhe"/>
  <lastmod>2021-01-28T18:33:44+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/visoki-niva-na-izlekuvane-na-khepatit-s-sa-postignati-v-zatvori-v-nyu-york</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/visoki-niva-na-izlekuvane-na-khepatit-s-sa-postignati-v-zatvori-v-nyu-york"/>
  <lastmod>2021-01-28T21:07:16+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vaksinaciya-za-covid-19-pri-khora-s-chernodrobni-zabolyavaniya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vaksinaciya-za-covid-19-pri-khora-s-chernodrobni-zabolyavaniya"/>
  <lastmod>2021-02-02T12:56:06+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/Kude-e-Bulgaria</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/Kude-e-Bulgaria"/>
  <lastmod>2021-03-24T11:04:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-s-ne-povishava-riska-ot-smrt-pri-covid-19</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-s-ne-povishava-riska-ot-smrt-pri-covid-19"/>
  <lastmod>2021-03-23T14:36:07+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/farmacevtichnite-kompanii-gilead-i-vir-obedinyavat-sili-za-namiraneto-na-lekarstvo-za-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/farmacevtichnite-kompanii-gilead-i-vir-obedinyavat-sili-za-namiraneto-na-lekarstvo-za-khepatit"/>
  <lastmod>2021-03-23T15:06:54+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vseki-den-u-nas-umirat-chetirima-dushi-ot-khepatit-b-i-s-poradi-lipsa-na-navremenna</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vseki-den-u-nas-umirat-chetirima-dushi-ot-khepatit-b-i-s-poradi-lipsa-na-navremenna"/>
  <lastmod>2021-03-29T14:29:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/be-prieta-purvata-nacionalna-programa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/be-prieta-purvata-nacionalna-programa"/>
  <lastmod>2021-04-01T14:57:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/zloupotrebata-s-alkokhol-po-vreme-na-pandemiyata-vodi-do-vlna-ot-smrtonosni-chernodrobni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/zloupotrebata-s-alkokhol-po-vreme-na-pandemiyata-vodi-do-vlna-ot-smrtonosni-chernodrobni"/>
  <lastmod>2021-04-14T13:23:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vas-obyavi-osporvanite-ot-nas-iziskvaniya-za-lechenie-na-hcv-za-nischozhni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vas-obyavi-osporvanite-ot-nas-iziskvaniya-za-lechenie-na-hcv-za-nischozhni"/>
  <lastmod>2021-04-20T22:01:15+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lechenieto-na-khepatit-s-namalyava-riska-ot-udar-i-infarkt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lechenieto-na-khepatit-s-namalyava-riska-ot-udar-i-infarkt"/>
  <lastmod>2021-04-26T17:25:00+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khorata-s-khiv-i-khepatit-v-tryabva-da-bdat-nablyudavani-za-rak-na-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khorata-s-khiv-i-khepatit-v-tryabva-da-bdat-nablyudavani-za-rak-na-cherniya-drob"/>
  <lastmod>2021-04-26T17:40:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izkhodt-ot-covid-19-pri-pacienti-s-avtoimunen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izkhodt-ot-covid-19-pri-pacienti-s-avtoimunen-khepatit"/>
  <lastmod>2021-04-26T17:46:11+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/evropeyskata-asociaciya-za-izuchavane-na-cherniya-drob-organizira-art-konkurs-za-pacienti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/evropeyskata-asociaciya-za-izuchavane-na-cherniya-drob-organizira-art-konkurs-za-pacienti"/>
  <lastmod>2021-05-15T10:20:47+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/szo-celite-za-eliminirane-na-khepatit-do-2030-g-ne-mogat-da-bdat-izplneni-bez-seriozno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/szo-celite-za-eliminirane-na-khepatit-do-2030-g-ne-mogat-da-bdat-izplneni-bez-seriozno"/>
  <lastmod>2021-06-18T10:48:11+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chernodrobnata-funkciya-se-podobryava-pri-povecheto-khora-s-ciroza-sled-izlekuvane-na-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chernodrobnata-funkciya-se-podobryava-pri-povecheto-khora-s-ciroza-sled-izlekuvane-na-khepatit"/>
  <lastmod>2021-06-23T15:54:19+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/imunoterapevtichniyat-podkhod-sreschu-virusa-na-khepatit-v-podsilva-t-kletkite-i-deystva-kato</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/imunoterapevtichniyat-podkhod-sreschu-virusa-na-khepatit-v-podsilva-t-kletkite-i-deystva-kato"/>
  <lastmod>2021-06-23T15:54:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/predavane-na-khepatit-s-po-polov-pt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/predavane-na-khepatit-s-po-polov-pt"/>
  <lastmod>2021-06-23T15:55:05+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ne-e-vprost-dali-da-se-testvash-koga-napravi-go-dnes</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ne-e-vprost-dali-da-se-testvash-koga-napravi-go-dnes"/>
  <lastmod>2021-07-27T09:21:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otvoreno-pismo-otnosno-nevzmozhnostta-za-osschestvyavane-na-detski-chernodrobni-transplantacii</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otvoreno-pismo-otnosno-nevzmozhnostta-za-osschestvyavane-na-detski-chernodrobni-transplantacii"/>
  <lastmod>2021-08-21T09:39:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/po-slab-otgovor-na-vaksinata-sreschu-covid-19-pri-khora-s-naprednala-chernodrobna-fibroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/po-slab-otgovor-na-vaksinata-sreschu-covid-19-pri-khora-s-naprednala-chernodrobna-fibroza"/>
  <lastmod>2021-10-04T19:36:07+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/decata-na-mayki-ss-zatlstyavane-sa-s-po-visok-risk-ot-chernodrobna-bolest</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/decata-na-mayki-ss-zatlstyavane-sa-s-po-visok-risk-ot-chernodrobna-bolest"/>
  <lastmod>2021-10-04T19:40:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/do-pet-godini-mozhe-da-se-poyavi-vaksina-sreschu-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/do-pet-godini-mozhe-da-se-poyavi-vaksina-sreschu-khepatit-s"/>
  <lastmod>2021-10-04T19:44:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/universalen-skrining-za-khepatit-v-mozhe-da-spasi-zhivot-i-da-skrati-razkhodite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/universalen-skrining-za-khepatit-v-mozhe-da-spasi-zhivot-i-da-skrati-razkhodite"/>
  <lastmod>2021-10-04T19:54:27+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/314000</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/314000"/>
  <lastmod>2025-07-24T18:19:05+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tenofovir-polpharma-otnovo-nalichen-v-blgariya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tenofovir-polpharma-otnovo-nalichen-v-blgariya"/>
  <lastmod>2022-02-08T19:29:07+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dlgiyat-covid-se-svrzva-s-povishen-risk-ot-bolest-na-omazneniya-cheren-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dlgiyat-covid-se-svrzva-s-povishen-risk-ot-bolest-na-omazneniya-cheren-drob"/>
  <lastmod>2022-02-21T18:51:00+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kakvi-aerobni-uprazhneniya-namalyavat-mazninite-v-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kakvi-aerobni-uprazhneniya-namalyavat-mazninite-v-cherniya-drob"/>
  <lastmod>2022-02-21T18:54:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pri-nyakoi-khora-riskt-ot-rak-na-cherniya-drob-ostava-vpreki-izlekuvaneto-na-khepatit-c</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pri-nyakoi-khora-riskt-ot-rak-na-cherniya-drob-ostava-vpreki-izlekuvaneto-na-khepatit-c"/>
  <lastmod>2022-03-06T16:47:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sobschenie-do-pacientite-s-khronichen-khepatit-v-lekuvaschi-se-v-gr-varna</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sobschenie-do-pacientite-s-khronichen-khepatit-v-lekuvaschi-se-v-gr-varna"/>
  <lastmod>2022-03-12T16:13:30+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izpolzvaneto-na-antikhistamini-namalyava-napolovina-riska-ot-rak-na-cherniya-drob-pri-khora-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izpolzvaneto-na-antikhistamini-namalyava-napolovina-riska-ot-rak-na-cherniya-drob-pri-khora-s"/>
  <lastmod>2022-03-15T15:57:56+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/depresiyata-trevozhnostta-i-kognitivnite-funkcii-se-podobryavat-sled-izlekuvane-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/depresiyata-trevozhnostta-i-kognitivnite-funkcii-se-podobryavat-sled-izlekuvane-na-khepatit-s"/>
  <lastmod>2022-04-13T14:32:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-v-i-s-sa-stanali-po-chesti-pri-bremenni-zheni</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-v-i-s-sa-stanali-po-chesti-pri-bremenni-zheni"/>
  <lastmod>2022-04-13T14:38:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-da-izbegnem-povtorno-infektirane-s-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-da-izbegnem-povtorno-infektirane-s-khepatit-s"/>
  <lastmod>2022-04-26T15:28:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/opasna-medicina-istoriyata-zad-eksperimentite-s-khepatit-vrkhu-khora</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/opasna-medicina-istoriyata-zad-eksperimentite-s-khepatit-vrkhu-khora"/>
  <lastmod>2022-05-30T09:32:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sobscheni-sa-pochti-200-sluchaya-na-neobyasnim-ostr-khepatit-pri-deca</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sobscheni-sa-pochti-200-sluchaya-na-neobyasnim-ostr-khepatit-pri-deca"/>
  <lastmod>2022-05-10T09:35:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/navremennoto-otkrivane-na-khepatita-nosi-socialni-i-ikonomicheski-polzi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/navremennoto-otkrivane-na-khepatita-nosi-socialni-i-ikonomicheski-polzi"/>
  <lastmod>2022-05-14T17:28:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ukrayna-uslugi-za-virusen-khepatit-i-namalyavane-na-vredite-za-bezhanci</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ukrayna-uslugi-za-virusen-khepatit-i-namalyavane-na-vredite-za-bezhanci"/>
  <lastmod>2022-06-06T11:24:48+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/analiz-na-antivirusnata-efikasnost-sled-preminavane-ot-trgovska-marka-km-generichen-entekavir</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/analiz-na-antivirusnata-efikasnost-sled-preminavane-ot-trgovska-marka-km-generichen-entekavir"/>
  <lastmod>2022-06-06T11:47:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otbelyazvame-mezhdunarodniya-nash-den</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otbelyazvame-mezhdunarodniya-nash-den"/>
  <lastmod>2022-06-08T22:07:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzhenie-khepaktiv-sche-vzeme-uchastie-vv-forum-adresirasch-stigmata-i-diskriminaciyata-sred</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzhenie-khepaktiv-sche-vzeme-uchastie-vv-forum-adresirasch-stigmata-i-diskriminaciyata-sred"/>
  <lastmod>2022-06-15T20:47:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vertikalnoto-predavane-na-khepatit-s-e-po-chesto-sreschano-ot-ochakvanoto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vertikalnoto-predavane-na-khepatit-s-e-po-chesto-sreschano-ot-ochakvanoto"/>
  <lastmod>2024-01-31T12:26:27+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khorata-s-diabet-ili-zloupotrebyavaschi-s-alkokhol-sa-v-po-golyam-risk-ot-tezhka-fibroza-sled</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khorata-s-diabet-ili-zloupotrebyavaschi-s-alkokhol-sa-v-po-golyam-risk-ot-tezhka-fibroza-sled"/>
  <lastmod>2022-06-15T11:29:37+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sled-dlgodishni-usiliya-izsledvaniyata-za-khepatit-v-i-s-byakha-vklyucheni-v-godishniya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sled-dlgodishni-usiliya-izsledvaniyata-za-khepatit-v-i-s-byakha-vklyucheni-v-godishniya"/>
  <lastmod>2022-07-01T17:10:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lechenieto-na-khepatit-v-se-vrscha-km-chertozhnata-dska-kazvat-izsledovatelite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lechenieto-na-khepatit-v-se-vrscha-km-chertozhnata-dska-kazvat-izsledovatelite"/>
  <lastmod>2022-07-13T09:51:26+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepaktiv-sche-vzeme-uchastie-v-mezhdunaroden-uebinar-posveten-na-svetovniya-den-za-borba-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepaktiv-sche-vzeme-uchastie-v-mezhdunaroden-uebinar-posveten-na-svetovniya-den-za-borba-s"/>
  <lastmod>2022-07-19T16:11:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatitt-ne-mozhe-da-chaka-izsledvay-se-sega</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatitt-ne-mozhe-da-chaka-izsledvay-se-sega"/>
  <lastmod>2022-07-27T14:10:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/eksperimentalna-kombinaciya-za-lechenie-na-khepatit-b-potiska-klyuchoviya-marker-no-ne-uspyava</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/eksperimentalna-kombinaciya-za-lechenie-na-khepatit-b-potiska-klyuchoviya-marker-no-ne-uspyava"/>
  <lastmod>2022-08-15T10:02:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/namerena-e-veroyatna-prichina-za-misterioznoto-ognische-na-detski-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/namerena-e-veroyatna-prichina-za-misterioznoto-ognische-na-detski-khepatit"/>
  <lastmod>2022-10-11T12:47:45+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pri-khorata-izlekuvani-ot-khepatit-s-riskt-ot-bbrechno-zabolyavane-prodlzhava-da-e-zavishen</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pri-khorata-izlekuvani-ot-khepatit-s-riskt-ot-bbrechno-zabolyavane-prodlzhava-da-e-zavishen"/>
  <lastmod>2022-08-26T15:12:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/seriozen-rst-pri-smrtnite-sluchai-ot-alkokholna-ciroza</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/seriozen-rst-pri-smrtnite-sluchai-ot-alkokholna-ciroza"/>
  <lastmod>2022-08-26T15:15:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kratkosrochno-lechenie-predotvratyava-khepatit-s-sled-transplantaciya-na-organ</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kratkosrochno-lechenie-predotvratyava-khepatit-s-sled-transplantaciya-na-organ"/>
  <lastmod>2022-08-26T15:19:05+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/usiliyata-za-vaksinirane-sreschu-khepatit-mogat-da-namalyat-razprostranenieto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/usiliyata-za-vaksinirane-sreschu-khepatit-mogat-da-namalyat-razprostranenieto"/>
  <lastmod>2022-10-19T15:06:23+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otkritie-mozhe-da-promeni-posokata-na-lechenie-na-chernodrobni-zabolyavaniya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otkritie-mozhe-da-promeni-posokata-na-lechenie-na-chernodrobni-zabolyavaniya"/>
  <lastmod>2022-10-19T15:09:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/bulevirtide-pokazva-obeschavaschi-rezultati-za-lechenie-na-khepatit-d</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/bulevirtide-pokazva-obeschavaschi-rezultati-za-lechenie-na-khepatit-d"/>
  <lastmod>2022-10-19T15:13:16+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vvezhdat-se-bezplatni-izsledvaniya-za-khepatit-v-i-s-i-chernodrobni-markeri</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vvezhdat-se-bezplatni-izsledvaniya-za-khepatit-v-i-s-i-chernodrobni-markeri"/>
  <lastmod>2022-10-31T11:07:02+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/spontannoto-izchistvane-na-khepatit-s-e-ryadko-sreschano-pri-khomo-i-biseksualnite-mzhe-s-khiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/spontannoto-izchistvane-na-khepatit-s-e-ryadko-sreschano-pri-khomo-i-biseksualnite-mzhe-s-khiv"/>
  <lastmod>2022-11-21T11:51:19+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/agenciyata-za-khranite-i-lekarstvata-fda-odobryava-medikamenta-sreschu-avtoimunen-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/agenciyata-za-khranite-i-lekarstvata-fda-odobryava-medikamenta-sreschu-avtoimunen-khepatit"/>
  <lastmod>2022-11-21T11:57:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prichinite-za-rak-na-cherniya-drob-se-promenyat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prichinite-za-rak-na-cherniya-drob-se-promenyat"/>
  <lastmod>2022-11-21T12:01:52+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzhenie-khepaktiv-organizira-poredica-bezplatni-uebinari-svrzani-ss-zdraveto-na-cherniya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzhenie-khepaktiv-organizira-poredica-bezplatni-uebinari-svrzani-ss-zdraveto-na-cherniya"/>
  <lastmod>2023-02-11T10:47:29+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzmozhno-e-vremenno-doplaschane-pri-poluchavaneto-na-tenofovir-maylanzentivapolfarma</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzmozhno-e-vremenno-doplaschane-pri-poluchavaneto-na-tenofovir-maylanzentivapolfarma"/>
  <lastmod>2022-12-19T12:43:25+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nacionalnata-zdravna-sluzhba-na-angliya-sche-eliminira-khepatit-s-predi-ostanaliya-svyat</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nacionalnata-zdravna-sluzhba-na-angliya-sche-eliminira-khepatit-s-predi-ostanaliya-svyat"/>
  <lastmod>2023-01-02T11:05:54+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/okultna-infekciya-s-virusa-na-khepatit-b-podcenena-globalna-zaplakha-za-zdraveto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/okultna-infekciya-s-virusa-na-khepatit-b-podcenena-globalna-zaplakha-za-zdraveto"/>
  <lastmod>2023-01-02T11:08:51+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/indikatori-za-tezhko-uvrezhdane-pri-pacienti-s-khronichen-khepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/indikatori-za-tezhko-uvrezhdane-pri-pacienti-s-khronichen-khepatit-b"/>
  <lastmod>2023-05-15T15:22:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uebinar-zdraveto-na-cherniya-drob-chernodrobna-steatoza-i-nealkokholen-steatokhepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uebinar-zdraveto-na-cherniya-drob-chernodrobna-steatoza-i-nealkokholen-steatokhepatit"/>
  <lastmod>2023-01-09T10:08:43+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lechenie-za-khepatit-v-v-proces-na-izsledvane-promenya-celta-si-ot-potiskane-km-izlekuvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lechenie-za-khepatit-v-v-proces-na-izsledvane-promenya-celta-si-ot-potiskane-km-izlekuvane"/>
  <lastmod>2023-02-06T10:36:34+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/eksperimentalna-vaksina-sreschu-khiv-szdava-shiroko-neutraliziraschi-antitela</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/eksperimentalna-vaksina-sreschu-khiv-szdava-shiroko-neutraliziraschi-antitela"/>
  <lastmod>2023-03-30T11:57:43+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/resmetirom-podobryava-rezultatite-ot-omaznyavane-i-fibroza-na-cherniya-drob-v-izsledvane-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/resmetirom-podobryava-rezultatite-ot-omaznyavane-i-fibroza-na-cherniya-drob-v-izsledvane-na"/>
  <lastmod>2023-02-06T11:01:52+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uebinar-khepatit-s-i-rak-na-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uebinar-khepatit-s-i-rak-na-cherniya-drob"/>
  <lastmod>2023-02-22T09:57:20+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/16-fevruari-pokana-za-uchastie-v-nacionalen-forum-na-tema-virusni-khepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/16-fevruari-pokana-za-uchastie-v-nacionalen-forum-na-tema-virusni-khepatiti"/>
  <lastmod>2023-02-15T12:22:36+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/viber-kanal</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/viber-kanal"/>
  <lastmod>2023-02-15T16:54:45+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nacionalen-forum-prizovava-za-uskoren-skrining-i-lechenie-na-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nacionalen-forum-prizovava-za-uskoren-skrining-i-lechenie-na-khepatit-v-i-s"/>
  <lastmod>2023-02-19T12:05:39+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uebinar-khepatit-v-riskove-prosledyavane-lechenie</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uebinar-khepatit-v-riskove-prosledyavane-lechenie"/>
  <lastmod>2023-03-20T10:23:48+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/uebinar-emocionalno-spravyane-s-bolestta-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/uebinar-emocionalno-spravyane-s-bolestta-khepatit"/>
  <lastmod>2023-04-20T12:11:31+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/novo-izsledvane-na-szo-diagnosticiraneto-na-khepatit-s-da-stane-po-dostpno-i-po-blizko-do</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/novo-izsledvane-na-szo-diagnosticiraneto-na-khepatit-s-da-stane-po-dostpno-i-po-blizko-do"/>
  <lastmod>2023-04-24T10:48:40+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/terapiyata-za-khepatit-v-na-kompaniyata-gsk-zapochva-izpitvaniya-ot-faza-3</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/terapiyata-za-khepatit-v-na-kompaniyata-gsk-zapochva-izpitvaniya-ot-faza-3"/>
  <lastmod>2023-04-24T10:54:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/reduvaneto-na-dni-ss-i-bez-khranene-se-svrzva-s-po-niski-niva-na-chernodrobno-omaznyavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/reduvaneto-na-dni-ss-i-bez-khranene-se-svrzva-s-po-niski-niva-na-chernodrobno-omaznyavane"/>
  <lastmod>2023-04-25T08:31:27+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/chetiri-sedmici-mozhe-da-sa-tvrde-kratki-za-lechenie-na-skoroshen-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/chetiri-sedmici-mozhe-da-sa-tvrde-kratki-za-lechenie-na-skoroshen-khepatit-s"/>
  <lastmod>2023-05-01T10:09:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/po-plten-cheren-drob-se-svrzva-s-rak-na-cherniya-drob-pri-khora-s-khepatit-c-ili-nafld</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/po-plten-cheren-drob-se-svrzva-s-rak-na-cherniya-drob-pri-khora-s-khepatit-c-ili-nafld"/>
  <lastmod>2023-05-01T10:14:11+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/konsumaciyata-na-brzo-khranene-se-svrzva-s-mastna-chernodrobna-bolest</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/konsumaciyata-na-brzo-khranene-se-svrzva-s-mastna-chernodrobna-bolest"/>
  <lastmod>2023-05-01T10:18:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzekhme-uchastie-v-mezhdunarodna-srescha-za-redki-avtoimunni-zabolyavaniya-na-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzekhme-uchastie-v-mezhdunarodna-srescha-za-redki-avtoimunni-zabolyavaniya-na-cherniya-drob"/>
  <lastmod>2023-06-06T16:34:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nova-mashina-za-dializa-dokazva-efektivnostta-si-pri-lechenieto-na-chernodrobna-nedostatchnost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nova-mashina-za-dializa-dokazva-efektivnostta-si-pri-lechenieto-na-chernodrobna-nedostatchnost"/>
  <lastmod>2023-06-26T11:21:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/riskt-ot-smrt-pri-pacientite-s-ciroza-e-nad-dva-pti-po-golyam-v-stranite-s-niski-dokhodi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/riskt-ot-smrt-pri-pacientite-s-ciroza-e-nad-dva-pti-po-golyam-v-stranite-s-niski-dokhodi"/>
  <lastmod>2023-06-26T11:27:03+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khronichniyat-khepatit-s-se-svrzva-s-po-brzo-biologichno-ostaryavane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khronichniyat-khepatit-s-se-svrzva-s-po-brzo-biologichno-ostaryavane"/>
  <lastmod>2023-06-26T11:30:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tatuirovkite-i-khepatit-s-kakvi-sa-riskovete</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tatuirovkite-i-khepatit-s-kakvi-sa-riskovete"/>
  <lastmod>2023-06-26T11:41:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kampaniya-po-povod-svetovniya-den-za-borba-s-khepatita-2023</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kampaniya-po-povod-svetovniya-den-za-borba-s-khepatita-2023"/>
  <lastmod>2023-07-21T10:45:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otbelyazvame-svetovniya-den-za-borba-s-khepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otbelyazvame-svetovniya-den-za-borba-s-khepatita"/>
  <lastmod>2023-07-28T15:25:32+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vazhno-otpadnakha-ogranichavaschi-usloviya-pri-lechenieto-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vazhno-otpadnakha-ogranichavaschi-usloviya-pri-lechenieto-na-khepatit-s"/>
  <lastmod>2023-08-25T13:35:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/10-septemvri-e-den-za-informiranost-za-prvichniya-biliaren-kholangit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/10-septemvri-e-den-za-informiranost-za-prvichniya-biliaren-kholangit"/>
  <lastmod>2023-09-08T09:27:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepaktiv-vze-uchastie-v-diskusiya-po-povod-svetovniya-den-za-bezopasnost-na-pacienta</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepaktiv-vze-uchastie-v-diskusiya-po-povod-svetovniya-den-za-bezopasnost-na-pacienta"/>
  <lastmod>2023-09-18T22:43:10+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/populyarizirane-na-vaksiniraneto-sreschu-khepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/populyarizirane-na-vaksiniraneto-sreschu-khepatit-b"/>
  <lastmod>2023-10-03T11:13:59+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nivata-na-smrtnost-se-zapazvat-visoki-sled-izlekuvaneto-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nivata-na-smrtnost-se-zapazvat-visoki-sled-izlekuvaneto-na-khepatit-s"/>
  <lastmod>2023-10-03T11:17:35+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/polozhitelni-rezultati-ot-izpitvaneto-ot-faza-3-na-preparata-bulevirtide</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/polozhitelni-rezultati-ot-izpitvaneto-ot-faza-3-na-preparata-bulevirtide"/>
  <lastmod>2023-10-03T11:21:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nyama-nuzhda-da-se-ogranichava-terapiyata-s-daa-za-khepatit-s-pri-upotrebata-na-alkokhol</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nyama-nuzhda-da-se-ogranichava-terapiyata-s-daa-za-khepatit-s-pri-upotrebata-na-alkokhol"/>
  <lastmod>2023-12-14T07:17:32+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/ezhednevnoto-konsumirane-na-bezalkokholni-napitki-e-svrzano-s-povishen-risk-ot-chernodrobno</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/ezhednevnoto-konsumirane-na-bezalkokholni-napitki-e-svrzano-s-povishen-risk-ot-chernodrobno"/>
  <lastmod>2023-10-25T12:48:09+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepaktiv-be-sred-lektorite-na-godishniya-kongres-na-bulnozo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepaktiv-be-sred-lektorite-na-godishniya-kongres-na-bulnozo"/>
  <lastmod>2023-10-31T08:45:01+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/szo-privetstva-egipet-za-napredka-pri-eliminirane-na-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/szo-privetstva-egipet-za-napredka-pri-eliminirane-na-khepatit-s"/>
  <lastmod>2024-01-16T18:42:26+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/istoriya-na-vaksinata-sreschu-khepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/istoriya-na-vaksinata-sreschu-khepatit-b"/>
  <lastmod>2024-01-17T07:47:15+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nakratko-za-avtoimunniya-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nakratko-za-avtoimunniya-khepatit"/>
  <lastmod>2024-01-24T15:49:08+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vzemete-uchastie-v-prvoto-sociologichesko-prouchvane-sred-pacienti-s-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vzemete-uchastie-v-prvoto-sociologichesko-prouchvane-sred-pacienti-s-khepatit-v-i-s"/>
  <lastmod>2024-02-05T10:37:31+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-da-proverim-statusa-na-elektronen-protokol-za-otpuskane-na-lechenie-za-khepatit-vs</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-da-proverim-statusa-na-elektronen-protokol-za-otpuskane-na-lechenie-za-khepatit-vs"/>
  <lastmod>2024-02-12T10:40:57+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tryabva-li-poveche-khora-da-se-lekuvat-ot-khepatit-b</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tryabva-li-poveche-khora-da-se-lekuvat-ot-khepatit-b"/>
  <lastmod>2024-03-05T18:28:39+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/prvoto-odobreno-lekarstvo-za-steatokhepatit-veche-e-fakt</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/prvoto-odobreno-lekarstvo-za-steatokhepatit-veche-e-fakt"/>
  <lastmod>2024-03-18T08:24:27+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/nay-vazhnoto-za-HEV</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/nay-vazhnoto-za-HEV"/>
  <lastmod>2024-04-10T09:30:55+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/szo-alarmira-infekciite-s-virusen-khepatit-otnemat-3500-zhivota-vseki-den</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/szo-alarmira-infekciite-s-virusen-khepatit-otnemat-3500-zhivota-vseki-den"/>
  <lastmod>2024-04-22T09:42:25+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/WHD2024</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/WHD2024"/>
  <lastmod>2024-07-15T09:01:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/webinar-25-July</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/webinar-25-July"/>
  <lastmod>2024-07-18T07:04:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledvaniyata-za-khepatit-v-i-s-sa-ot-klyuchovo-znachenie-po-vreme-na-bremennost</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledvaniyata-za-khepatit-v-i-s-sa-ot-klyuchovo-znachenie-po-vreme-na-bremennost"/>
  <lastmod>2024-07-19T10:35:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/funkcionalen-lek-za-khepatit-v-giga-2339-vliza-vv-faza-1-na-klinichno-prouchvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/funkcionalen-lek-za-khepatit-v-giga-2339-vliza-vv-faza-1-na-klinichno-prouchvane"/>
  <lastmod>2024-08-12T08:32:52+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatociti-golyamata-tayna-na-vasheto-tyalo</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatociti-golyamata-tayna-na-vasheto-tyalo"/>
  <lastmod>2024-09-09T21:59:42+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/pacientite-sche-bdat-izvestyavani-ss-sobschenie-za-statusa-na-tekhniya-protokol</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/pacientite-sche-bdat-izvestyavani-ss-sobschenie-za-statusa-na-tekhniya-protokol"/>
  <lastmod>2024-09-16T06:57:00+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/precision-biosciences-planira-klinichno-prouchvane-na-revolyucionen-podkhod-za-lechenie-na</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/precision-biosciences-planira-klinichno-prouchvane-na-revolyucionen-podkhod-za-lechenie-na"/>
  <lastmod>2024-10-04T08:12:50+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/oktomvri-e-mesec-na-osvedomenostta-za-rak-na-cherniya-drob</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/oktomvri-e-mesec-na-osvedomenostta-za-rak-na-cherniya-drob"/>
  <lastmod>2024-10-25T09:43:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/18-25-noemvri-otbelyazvame-evropeyskata-testing-sedmica</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/18-25-noemvri-otbelyazvame-evropeyskata-testing-sedmica"/>
  <lastmod>2024-11-15T11:42:52+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/kak-egipet-eliminira-khepatit-s-za-deset-godini</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/kak-egipet-eliminira-khepatit-s-za-deset-godini"/>
  <lastmod>2024-11-28T10:05:33+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/veseli-praznici-ot-sdruzhenie-khepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/veseli-praznici-ot-sdruzhenie-khepaktiv"/>
  <lastmod>2024-12-21T07:14:49+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/izsledovateli-napravikha-probiv-v-lechenieto-na-khepatocelularniya-karcinom</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/izsledovateli-napravikha-probiv-v-lechenieto-na-khepatocelularniya-karcinom"/>
  <lastmod>2025-01-17T18:59:50+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/imdusiran-postiga-funkcionalno-izlekuvane-pri-50-ot-pacientite-s-khronichen-khepatit-v</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/imdusiran-postiga-funkcionalno-izlekuvane-pri-50-ot-pacientite-s-khronichen-khepatit-v"/>
  <lastmod>2025-02-10T15:28:28+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/patogenite-ne-zachitat-politicite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/patogenite-ne-zachitat-politicite"/>
  <lastmod>2025-02-18T10:34:40+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/mechtata-na-edin-chovek-za-tanzaniya-bez-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/mechtata-na-edin-chovek-za-tanzaniya-bez-khepatit"/>
  <lastmod>2025-03-30T11:47:36+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/organizirame-preskonferenciya-na-tema-sche-uspee-li-vtorata-nacionalna-programa-za-prevenciya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/organizirame-preskonferenciya-na-tema-sche-uspee-li-vtorata-nacionalna-programa-za-prevenciya"/>
  <lastmod>2025-05-09T08:35:56+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/blgariya-zastrashitelno-izostava-pri-diagnostikata-i-lechenieto-na-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/blgariya-zastrashitelno-izostava-pri-diagnostikata-i-lechenieto-na-khepatit-v-i-s"/>
  <lastmod>2025-05-12T21:49:54+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/amerikanskata-agenciya-po-khrani-i-lekarstva-odobri-mavyret-za-lechenie-i-na-ostr-khepatit-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/amerikanskata-agenciya-po-khrani-i-lekarstva-odobri-mavyret-za-lechenie-i-na-ostr-khepatit-s"/>
  <lastmod>2025-06-21T13:58:57+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/WHD2025</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/WHD2025"/>
  <lastmod>2025-07-28T09:28:38+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/HDV%20leaflet</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/HDV%20leaflet"/>
  <lastmod>2025-07-23T17:56:41+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vnesokhme-predlozheniya-za-promeni-v-iziskvaniyata-za-lechenie-na-khepatit-v-i-s</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vnesokhme-predlozheniya-za-promeni-v-iziskvaniyata-za-lechenie-na-khepatit-v-i-s"/>
  <lastmod>2025-07-25T11:29:08+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/otbelyazvame-mezhdunarodniya-den-za-informiranost-za-prvichen-biliaren-kholangit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/otbelyazvame-mezhdunarodniya-den-za-informiranost-za-prvichen-biliaren-kholangit"/>
  <lastmod>2025-09-01T03:51:49+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/vizhte-videoto-po-povod-svetovniya-pbkh-den-0</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/vizhte-videoto-po-povod-svetovniya-pbkh-den-0"/>
  <lastmod>2025-09-12T15:07:30+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/sdruzhenie-khepaktiv-prekrati-chlenstvoto-si-v-nacionalna-pacientska-organizaciya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/sdruzhenie-khepaktiv-prekrati-chlenstvoto-si-v-nacionalna-pacientska-organizaciya"/>
  <lastmod>2025-10-24T12:46:10+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/tri-novi-specializirani-kliniki-za-lechenie-na-virusni-khepatiti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/tri-novi-specializirani-kliniki-za-lechenie-na-virusni-khepatiti"/>
  <lastmod>2025-11-02T08:24:02+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/thervacb-nadezhda-za-nov-podhod</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/thervacb-nadezhda-za-nov-podhod"/>
  <lastmod>2025-11-22T09:37:26+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khronichniyat-khepatit-c-uvelichava-riska-ot-rak-na-pankreasa</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khronichniyat-khepatit-c-uvelichava-riska-ot-rak-na-pankreasa"/>
  <lastmod>2026-01-14T15:43:05+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/NoMoreBiopsyHBV</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/NoMoreBiopsyHBV"/>
  <lastmod>2026-02-19T12:17:14+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/NoviIziskvaniaHCV</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/NoviIziskvaniaHCV"/>
  <lastmod>2026-02-20T18:34:53+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/one_medicine_HBV_HCV</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/one_medicine_HBV_HCV"/>
  <lastmod>2026-03-20T09:25:26+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/FDA_HDV_treatment</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/FDA_HDV_treatment"/>
  <lastmod>2026-06-02T18:19:58+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/khepatit-b-i-c-tikhata-zaplakha-koyato-uvrezhda-bez-simptomi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/khepatit-b-i-c-tikhata-zaplakha-koyato-uvrezhda-bez-simptomi"/>
  <lastmod>2026-06-08T15:30:52+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/WHD2026</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/WHD2026"/>
  <lastmod>2026-07-28T10:40:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/dnes-otbelyazvame-svetovniya-den-za-borba-s-khepatita</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/dnes-otbelyazvame-svetovniya-den-za-borba-s-khepatita"/>
  <lastmod>2026-07-28T10:29:14+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/lechenieto-na-HCV-spestyava-miliardi-dolari-za-zdraveopazvane-i-spasyava-zhivoti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/lechenieto-na-HCV-spestyava-miliardi-dolari-za-zdraveopazvane-i-spasyava-zhivoti"/>
  <lastmod>2026-08-10T12:29:18+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/yaponiya-odobri-prvoto-lekarstvo-za-funkcionalno-izlekuvane</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/yaponiya-odobri-prvoto-lekarstvo-za-funkcionalno-izlekuvane"/>
  <lastmod>2026-08-26T14:59:04+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/news/startira-mezhdunarodnata-informacionna-kampaniya-ne-ste-nevidimi</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/news/startira-mezhdunarodnata-informacionna-kampaniya-ne-ste-nevidimi"/>
  <lastmod>2026-09-08T11:07:01+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/"/>
  <lastmod>2018-06-26T10:04:24+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/celi-koito-si-postava-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/celi-koito-si-postava-sdruzenie-hepaktiv"/>
  <lastmod>2018-05-12T14:22:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/forumt-na-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/forumt-na-sdruzenie-hepaktiv"/>
  <lastmod>2018-05-12T14:22:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/kontakti</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/kontakti"/>
  <lastmod>2026-09-12T09:24:27+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/kak-bese-szdadeno-sdruzenieto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/kak-bese-szdadeno-sdruzenieto"/>
  <lastmod>2018-05-12T14:22:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/koi-sa-khorata-zad-sdruzhenieto</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/koi-sa-khorata-zad-sdruzhenieto"/>
  <lastmod>2019-11-28T10:31:46+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/dobre-dosl-na-saita-na-sdruzenie-hepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/dobre-dosl-na-saita-na-sdruzenie-hepaktiv"/>
  <lastmod>2018-05-12T14:22:51+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/ustav-na-sdruzhenie-khepaktiv</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/ustav-na-sdruzhenie-khepaktiv"/>
  <lastmod>2019-06-18T13:12:52+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/individualni-konsultacii-za-emocionalna-podkrepa-na-pacienti-s-khepatit</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/individualni-konsultacii-za-emocionalna-podkrepa-na-pacienti-s-khepatit"/>
  <lastmod>2023-12-03T09:31:36+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/partnori</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/partnori"/>
  <lastmod>2023-01-23T18:52:20+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/politika-za-biskvitkite</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/politika-za-biskvitkite"/>
  <lastmod>2019-10-24T12:14:17+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/lekarstveni-vzaimodeystviya</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/lekarstveni-vzaimodeystviya"/>
  <lastmod>2020-03-08T17:19:42+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/FAQ</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/FAQ"/>
  <lastmod>2025-01-17T18:45:16+02:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/informacionni-materiali</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/informacionni-materiali"/>
  <lastmod>2025-07-23T17:17:12+03:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.hepactive.org/PBC</loc>
  <xhtml:link rel="alternate" hreflang="bg" href="https://www.hepactive.org/PBC"/>
  <lastmod>2026-09-08T08:54:33+03:00</lastmod>
  <priority>0.5</priority>
 </url>
</urlset>
